656 results on '"Y K Chan"'
Search Results
102. Prospective clinical trial to evaluate safety and feasibility of using a single port flexible robotic system for transoral head and neck surgery
- Author
-
Cherrie W K Ng, Michael C. F. Tong, Eddy W.Y. Wong, Philip Wai Yan Chiu, Raymond K. Y. Tsang, Jason Y. K. Chan, F. Christopher Holsinger, and Simon S.M. Ng
- Subjects
Adult ,Male ,Larynx ,Cancer Research ,medicine.medical_specialty ,Laryngectomy ,03 medical and health sciences ,Clinical Trials, Phase II as Topic ,0302 clinical medicine ,Robotic Surgical Procedures ,Transoral robotic surgery ,otorhinolaryngologic diseases ,Clinical endpoint ,Humans ,Medicine ,Robotic surgery ,Stage (cooking) ,030223 otorhinolaryngology ,Aged ,Neoplasm Staging ,Tonsillectomy ,business.industry ,Head and neck cancer ,Perioperative ,Middle Aged ,medicine.disease ,Surgery ,Clinical trial ,stomatognathic diseases ,medicine.anatomical_structure ,Oncology ,Head and Neck Neoplasms ,030220 oncology & carcinogenesis ,Female ,Oral Surgery ,business - Abstract
The aim of this study was to determine the clinical safety and feasibility of a novel single-port flexible robot for Transoral Robotic Surgery (TORS).This was a prospective phase II / IDEAL stage 2 clinical trial of both benign and malignant lesions of the head and neck. The primary endpoint included conversion rates and perioperative complications within 30 days following surgery. The study was registered on www.ClinicalTrials.gov (NCT03010813). The Fisher's exact test and Mann-Whitney U test were used to compare categorical, and non-parametric data for the trial. A p value0.05 was considered to be statistically significant. Statistical analysis was performed with SPSS 20.0 (IBM Corp., Armonk, New York) RESULTS: Twenty-one patients safely underwent TORS with the da Vinci SP (Intuitive Surgical Inc., Sunnyvale, CA) demonstrating the feasibility of access to the nasopharynx, oropharynx, larynx and hypopharynx. There were no conversions of the robotic surgical system. There were no serious adverse events or adverse events related to the use of the robot at 30-day follow-up for all patients.In a prospective Phase II clinical trial, a novel single-port flexible robotic system appears safe and feasible to use for transoral endoscopic head and neck surgery to access the nasopharynx, oropharynx, larynx and hypopharynx.
- Published
- 2019
- Full Text
- View/download PDF
103. Non-science majors learn about heat, temperature, and thermodynamics using the particulate nature of matter and guided-inquiry instruction
- Author
-
Julia Y. K. Chan and Christopher F. Bauer
- Subjects
Cooperative learning ,Energy conservation ,Structure (mathematical logic) ,Physics ,Data sharing ,Concept inventory ,Class (computer programming) ,Energy (esotericism) ,Mathematics education ,General Physics and Astronomy ,Thermal conduction - Abstract
Using a strong cooperative learning structure, an inquiry-based course Fire & Ice for non-science majors addresses the concepts of heat and temperature, as well as the historical development of these ideas. A coherent line of inquiry is developed based on the particulate nature of matter which guides students in constructing the concepts of kinetic molecular theory, absolute zero, thermal equilibrium, thermal conduction, energy conservation, and energy degradation. This is accomplished by interleaving hands-on explorations, question-based team discussions, data sharing, and whole class reviews. Student performance on an established thermal concept inventory shows significant improvement. Students also provided more mechanistic and detailed descriptions even as they struggle with precision of language. They perceived this course as different, challenging, accessible, social, and true to the label “inquiry.” A complete video and materials record of the course is available at the UNH Scholars Repository.
- Published
- 2019
- Full Text
- View/download PDF
104. Curved Laryngopharyngoscope With Flexible Next-Generation Robotic Surgical System for Transoral Hypopharyngeal Surgery: A Preclinical Evaluation
- Author
-
Taro Sugimoto, Ichiro Tateya, F. Christopher Holsinger, Kohtaro Eguchi, Jason Y. K. Chan, and Akira Shimizu
- Subjects
Male ,Natural Orifice Endoscopic Surgery ,Mouth ,medicine.medical_specialty ,Hypopharyngeal Neoplasms ,business.industry ,Robotic Surgical Procedures ,Hypopharyngeal cancer ,Equipment Design ,General Medicine ,Laryngoscopes ,Middle Aged ,medicine.disease ,Surgery ,Hypopharynx ,Otorhinolaryngology ,Transoral robotic surgery ,Cadaver ,Humans ,Medicine ,business ,Aged - Abstract
Objectives: The indication of transoral robotic surgery for hypopharyngeal cancer is limited because of poor accessibility. The aim of this study was to explore the efficacy of a curved laryngopharyngoscope used in combination with a next-generation flexible robotic surgical system for accessing and resecting the hypopharynx. Methods: A comparative evaluation of the curved laryngopharyngoscope versus standard straight-blade retractors using the flexible robotic surgical system was conducted on 2 cadavers. End points measured included visualization, accessibility, and ease of dissection for accessing and resecting the hypopharynx. Results: Visualization, accessibility, and dissection were superior with the curved laryngopharyngoscope in all subareas of the hypopharynx. The advantages of accessibility and visualization were much more evident in the cadaver with a high body mass index. Conclusions: These preclinical data suggest that using a curved laryngopharyngoscope in combination with a flexible robotic surgical system may lead to technical innovations concerning transoral surgery of the hypopharynx.
- Published
- 2019
- Full Text
- View/download PDF
105. Worldwide Occurrence and Investigations of Contamination of Herbal Medicines by Tropane Alkaloids
- Author
-
Thomas Y. K. Chan
- Subjects
tropane alkaloids ,anticholinergic poisoning ,herbal medicines ,medicinal plants ,Medicine - Abstract
Tropane alkaloids occur mainly in Solanaceae plants. In the present review, the main objective is to describe the worldwide occurrence and investigations of anticholinergic poisoning due to the contamination of herbal teas and herbs by tropane alkaloids. Tropane alkaloid poisoning can occur after consumption of any medicinal plant if Solanaceae plants or plant parts are present as contaminants. Globally, almost all reports in 1978–2014 involve herbal teas and one of the prescribed herbs in composite formulae. Contamination most likely occurs during harvest or processing. As for prescribed herbs, on-site inspection is necessary to exclude cross-contamination and accidental mix-up at the retail level. The diagnosis is confirmed by screening for the presence of Solanaceae species and tropane alkaloids. Herbal teas and herbs contaminated by tropane alkaloids can pose a serious health hazard because these relatively heat-stable alkaloids may exist in large quantities. The WHO repeatedly emphasises the importance of good agricultural and collection practices for medicinal plants. DNA barcoding is increasingly used to exclude the presence of contaminants (particularly toxic species) and product substitution. All suspected cases should be reported to health authorities so that investigations along the supply chain and early intervention measures to protect the public can be initiated.
- Published
- 2017
- Full Text
- View/download PDF
106. Regional Variations in the Risk and Severity of Ciguatera Caused by Eating Moray Eels
- Author
-
Thomas Y. K. Chan
- Subjects
ciguatera ,ciguatoxins ,moray eels ,Gymnothorax species ,Medicine - Abstract
Moray eels (Gymnothorax species) from tropical waters have long been known to be high-risk species, and the consumption of particularly the viscera or ungutted eels can result in severe ciguatera (known as Gymnothorax or moray eel poisoning), characterized by prominent neurological features. In this review, the main objective was to describe the risk and severity of ciguatera caused by eating moray eels in different parts of the world. Moray eels can accumulate very high ciguatoxin (CTX) levels in the flesh and particularly the liver. Therefore, even the smaller ones can be toxic and the consumption of an average portion (particularly liver) can result in severe or fatal ciguatera. Moray eels (particularly when ungutted) must never be served in gatherings since they can cause mass poisoning because of their large sizes and high CTX levels. Apart from regulatory measures restricting or excluding access, the public should be repeatedly warned to avoid eating moray eels.
- Published
- 2017
- Full Text
- View/download PDF
107. Fluid Biomarkers in HPV and Non-HPV Related Oropharyngeal Carcinomas: From Diagnosis and Monitoring to Prognostication—A Systematic Review
- Author
-
Shaun C. Lee, Karina K. C. Leung, Audrey C. Y. Chung, Elysia S. Y. Wong, Katie L. Meehan, and Jason Y. K. Chan
- Subjects
Carcinoma ,Organic Chemistry ,General Medicine ,Alphapapillomavirus ,Catalysis ,Computer Science Applications ,Inorganic Chemistry ,Oropharyngeal Neoplasms ,Humans ,Physical and Theoretical Chemistry ,Papillomaviridae ,Molecular Biology ,Biomarkers ,Spectroscopy - Abstract
Biomarkers are crucial in oncology, from detection and monitoring to guiding management and predicting treatment outcomes. Histological assessment of tissue biopsies is currently the gold standard for oropharyngeal cancers, but is technically demanding, invasive, and expensive. This systematic review aims to review current markers that are detectable in biofluids, which offer promising non-invasive alternatives in oropharyngeal carcinomas (OPCs). A total of 174 clinical trials from the PubMed search engine in the last 5 years were identified and screened by 4 independent reviewers. From these, 38 eligible clinical trials were found and subsequently reviewed. The biomarkers involved, categorized by human papillomavirus (HPV)-status, were further divided according to molecular and cellular levels. Recent trials investigating biomarkers for both HPV-positive and HPV-negative OPCs have approaches from various levels and different biofluids including plasma, oropharyngeal swabs, and oral rinse. Promising candidates have been found to aid in detection, staging, and predicting prognosis, in addition to well-established factors including HPV-status, drinking and smoking status. These studies also emphasize the possibility of enhancing prediction results and increasing statistical significance by multivariate analyses. Liquid biopsies offer promising assistance in enhancing personalized medicine for cancer treatment, from lowering barriers towards early screening, to facilitating de-escalation of treatment. However, further research is needed, and the combination of liquid biopsies with pre-existing methods, including in vivo imaging and invasive techniques such as neck dissections, could also be explored in future trials.
- Published
- 2022
- Full Text
- View/download PDF
108. Differential Effects of Estrogen Receptor Alpha and Beta on Endogenous Ligands of Peroxisome Proliferator-Activated Receptor Gamma in Papillary Thyroid Cancer
- Author
-
Jason Y. K. Chan, Yang Zhang, Lingbin Xue, Zhongqin Gong, C. Andrew van Hasselt, Michael Cf Tong, Minghui Wei, Xianhai Zeng, George G. Chen, Wei Wei, Nelson L.S. Tang, Shuqi Qiu, Shucai Yang, Alexander C. Vlantis, Jing Du, and Zhi-Min Liu
- Subjects
Adult ,Male ,endocrine system diseases ,Endocrinology, Diabetes and Metabolism ,Estrogen receptor ,Peroxisome proliferator-activated receptor ,Endogeny ,Apoptosis ,Ligands ,Diseases of the endocrine glands. Clinical endocrinology ,Papillary thyroid cancer ,peroxisome proliferator-activated receptor gamma ,Endocrinology ,Downregulation and upregulation ,Cell Movement ,Hydroxyeicosatetraenoic Acids ,medicine ,Tumor Cells, Cultured ,Estrogen Receptor beta ,Humans ,papillary thyroid cancer ,Thyroid Neoplasms ,Receptor ,Original Research ,PGJ2 ,Cell Proliferation ,chemistry.chemical_classification ,Chemistry ,Prostaglandin D2 ,estrogen receptors ,Middle Aged ,medicine.disease ,RC648-665 ,Prognosis ,PPAR gamma ,Linoleic Acids ,Thyroid Cancer, Papillary ,Cancer cell ,15(S)-HETE ,Cancer research ,Female ,Estrogen receptor alpha - Abstract
PurposeThe inhibition of estrogen receptor alpha (ERα) or the activation of ERβ can inhibit papillary thyroid cancer (PTC), but the precise mechanism is not known. We aimed to explore the role of ERα and ERβ on the production of endogenous peroxisome proliferator-activated receptor gamma (PPARγ) ligands in PTC.Methods2 PTC cell lines, 32 pairs of PTC tissues and matched normal thyroid tissues were used in this study. The levels of endogenous PPARγ ligands 15(S)-hydroxyeicosatetraenoic acid (15(S)-HETE), 13-S-hydroxyoctadecadienoic acid (13(S)-HODE), and15-deoxy-Δ12,14-prostaglandin J2 (PGJ2) were measured by ELISA.ResultsThe levels of PGJ2 and 15(S)-HETE were significantly reduced in PTC, but 13(S)-HODE was not changed. Activation of ERα or inhibition of ERβ significantly downregulated the production of PGJ2, 15(S)-HETE and 13(S)-HODE, whereas inhibition of ERα or activation of ERβ markedly upregulated the production of these three ligands. Application of endogenous PPARγ ligands inhibited growth, induced apoptosis of cancer cells, and promoted the efficacy of chemotherapy.ConclusionThe levels of endogenous PPARγ ligands PGJ2 and 15(S)-HETE are significantly decreased in PTC. The inhibition of ERα or activation of ERβ can inhibit PTC by stimulating the production of endogenous PPARγ ligands to induce apoptosis in cancer cells.
- Published
- 2021
109. Consenting clinics versus day of operation consent in elective hand surgery
- Author
-
J. Field, Matthew J. Y. K. Chan, and Michael Tredgett
- Subjects
Upper Extremity ,medicine.medical_specialty ,Informed Consent ,business.industry ,Elective Surgical Procedures ,General surgery ,medicine ,Humans ,Surgery ,Hand surgery ,business ,Hand ,Specialties, Surgical - Published
- 2021
110. Investigating Technology Implementation in a Neurosurgical Teleconsultation Program: A Case Study in Hong Kong.
- Author
-
Paul Jen-Hwa Hu, Patrick Y. K. Chau, Y. K. Chan, and John Kwok
- Published
- 2001
- Full Text
- View/download PDF
111. The clinical impact of chromosomal microarray on paediatric care in Hong Kong.
- Author
-
Victoria Q Tao, Kelvin Y K Chan, Yoyo W Y Chu, Gary T K Mok, Tiong Y Tan, Wanling Yang, So Lun Lee, Wing Fai Tang, Winnie W Y Tso, Elizabeth T Lau, Anita S Y Kan, Mary H Tang, Yu-Lung Lau, and Brian H Y Chung
- Subjects
Medicine ,Science - Abstract
ObjectiveTo evaluate the clinical impact of chromosomal microarray (CMA) on the management of paediatric patients in Hong Kong.MethodsWe performed NimbleGen 135k oligonucleotide array on 327 children with intellectual disability (ID)/developmental delay (DD), autism spectrum disorders (ASD), and/or multiple congenital anomalies (MCAs) in a university-affiliated paediatric unit from January 2011 to May 2013. The medical records of patients were reviewed in September 2013, focusing on the pathogenic/likely pathogenic CMA findings and their "clinical actionability" based on established criteria.ResultsThirty-seven patients were reported to have pathogenic/likely pathogenic results, while 40 had findings of unknown significance. This gives a detection rate of 11% for clinically significant (pathogenic/likely pathogenic) findings. The significant findings have prompted clinical actions in 28 out of 37 patients (75.7%), while the findings with unknown significance have led to further management recommendation in only 1 patient (p < 0.001). Nineteen out of the 28 management recommendations are "evidence-based" on either practice guidelines endorsed by a professional society (n = 9, Level 1) or peer-reviewed publications making medical management recommendation (n = 10, Level 2). CMA results impact medical management by precipitating referral to a specialist (n = 24); diagnostic testing (n = 25), surveillance of complications (n = 19), interventional procedure (n = 7), medication (n = 15) or lifestyle modification (n = 12).ConclusionThe application of CMA in children with ID/DD, ASD, and/or MCAs in Hong Kong results in a diagnostic yield of ∼ 11% for pathogenic/likely pathogenic results. Importantly the yield for clinically actionable results is 8.6%. We advocate using diagnostic yield of clinically actionable results to evaluate CMA as it provides information of both clinical validity and clinical utility. Furthermore, it incorporates evidence-based medicine into the practice of genomic medicine. The same framework can be applied to other genomic testing strategies enabled by next-generation sequencing.
- Published
- 2014
- Full Text
- View/download PDF
112. Whole-genome array CGH evaluation for replacing prenatal karyotyping in Hong Kong.
- Author
-
Anita S Y Kan, Elizabeth T Lau, W F Tang, Sario S Y Chan, Simon C K Ding, Kelvin Y K Chan, C P Lee, Pui Wah Hui, Brian H Y Chung, K Y Leung, Teresa Ma, Wing C Leung, and Mary H Y Tang
- Subjects
Medicine ,Science - Abstract
OBJECTIVE: To evaluate the effectiveness of whole-genome array comparative genomic hybridization (aCGH) in prenatal diagnosis in Hong Kong. METHODS: Array CGH was performed on 220 samples recruited prospectively as the first-tier test study. In addition 150 prenatal samples with abnormal fetal ultrasound findings found to have normal karyotypes were analyzed as a 'further-test' study using NimbleGen CGX-135K oligonucleotide arrays. RESULTS: Array CGH findings were concordant with conventional cytogenetic results with the exception of one case of triploidy. It was found in the first-tier test study that aCGH detected 20% (44/220) clinically significant copy number variants (CNV), of which 21 were common aneuploidies and 23 had other chromosomal imbalances. There were 3.2% (7/220) samples with CNVs detected by aCGH but not by conventional cytogenetics. In the 'further-test' study, the additional diagnostic yield of detecting chromosome imbalance was 6% (9/150). The overall detection for CNVs of unclear clinical significance was 2.7% (10/370) with 0.9% found to be de novo. Eleven loci of common CNVs were found in the local population. CONCLUSION: Whole-genome aCGH offered a higher resolution diagnostic capacity than conventional karyotyping for prenatal diagnosis either as a first-tier test or as a 'further-test' for pregnancies with fetal ultrasound anomalies. We propose replacing conventional cytogenetics with aCGH for all pregnancies undergoing invasive diagnostic procedures after excluding common aneuploidies and triploidies by quantitative fluorescent PCR. Conventional cytogenetics can be reserved for visualization of clinically significant CNVs.
- Published
- 2014
- Full Text
- View/download PDF
113. Biomedical Device Technology: Principles and Design
- Author
-
Anthony Y. K. Chan and Anthony Y. K. Chan
- Subjects
- Medical technology, Medical instruments and apparatus, Biomedical engineering
- Abstract
This book provides a comprehensive approach to studying the principles and design of biomedical devices and their applications in medicine. It is written for engineers and technologists who are interested in understanding the principles, design, and use of medical device technology. The book is also intended to be a textbook or reference for biomedical device technology courses in universities and colleges. It focuses on the applications, functions and principles of medical devices (which are the invariant components) and uses specific designs and constructions to illustrate the concepts where appropriate. Indication of use as well as common problems and hazards for each device type are included. This book selectively covers diagnostic and therapeutic devices that are either commonly used or whose principles and design represent typical applications of the technology. For those who would like to know more, a collection of published papers and book references has been added to the end of each chapter. In this third edition, many chapters have gone through revisions, some with significant updates and additions, to keep up with new applications and advancements in medical technology. A new appendix on infection prevention and control practices relating to medical devices is included. Based on requests, review questions are added for each chapter to help readers to assess their comprehension of the content material.
- Published
- 2023
114. Clinical Toxicology review metrics and expert reviewers, 2020
- Author
-
Donna Seger, Betty S. Chan, Martin F. Wilks, Bruno Mégarbane, Nicholas A. Buckley, J Allister Vale, Steven A. Seifert, Kirk L. Cumpston, Michael E. Mullins, Thomas Y. K. Chan, Simon H. L. Thomas, Ronald I. Kirschner, Service de Réanimation Médicale et Toxicologique [Hôpital Lariboisière], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Optimisation thérapeutique en Neuropsychopharmacologie (OPTeN (UMR_S_1144 / U1144)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), and Mégarbane, Bruno
- Subjects
[SDV.MHEP.ME] Life Sciences [q-bio]/Human health and pathology/Emerging diseases ,Medical education ,[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases ,MEDLINE ,General Medicine ,Clinical toxicology ,Toxicology ,[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract ,[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,[SDV.TOX] Life Sciences [q-bio]/Toxicology ,[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,[SDV.TOX]Life Sciences [q-bio]/Toxicology ,[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,[SDV.MHEP.PSR] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract ,Psychology - Abstract
The editors would like to acknowledge and thank all of those who assisted us in 2020 by providing peer review of the submitted manuscripts. Reviewers serve without pay. The time, effort and experti...
- Published
- 2021
- Full Text
- View/download PDF
115. Prevalence of diabetic and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities
- Author
-
H Appeltants, C Boesch, I Cromarty, D Carretta, S Romanov, U Windstetter, F Mibach, Jens Refsgaard, S Lebedev, F Proietti, M Y Tamimi, M C Gamboa, M Novikova, E Prada, K H Sim, E Messas, E Zherlitsyna, A Kalampalikis, N Nevolina, N Trocan, J Cohen, G Szto, R Gilabert Gómez, M Omelchenko, A Pinzani, D Goodwin, J Umaran Sánchez, Kim Fox, S H Dong, K Kronberg, E Castillo Lueña, T Ignatieva, S Joubert, C Macchi, S Lee, S Eidelman, F Alizon, S Chandra, M Akbar, D M Colquhoun, G Yanes Bowden, J de Juan Baguda, M Sebastian, C Wernham, K Miedema, R La Greca, C Morton, B S Jheeta, A C Tran, T Q Do, O Rodrigues, J Yan, S H Kim, R Jurgaitienė, Jean-Claude Tardif, R Baleón, D Hay, V Hennebelle, F Fazekas, R Davies, P Gratia, L Sorodoc, S Y Wu, C Martínez Sánchez, L Lopes Antunes, T H T Pham, I Suliman, M J Gómez Martinez, A Pernat, S H Hur, M Alanazy, L Zhabina, M Stanley, J Rogers, Y J Kim, S Geffroy, L K Andersen, S Coman, V Pedrosa del Moral, Y Garaud, J Krupicka, O Dzhkha, C Paul, M Jeżewska, B Mahler Mioto, V Abduvalieva, P Morra, L Kucheryava, C La Rosa, B Chan, M Wrębiak-Trznadel, A Kozlowski, M Sharif, L López Barreiro, V Kolesnikov, M Lawrence, A Tucker, C Okawabata, B La Hay, E Sadauskienė, B K Nguyen, L Bui, A Said, M E Ruíz Esparza, R K Saran, M S C Ho, E Homs Espinach, J R Romo Santana, J Forte De Carvalho, I Pattison, H H Phan, L Baleeva, L Kisiel, A López Granados, C Raters, F Paganelli, R Haberl, A P T Wong, D Xu, R Jagathesan, L Grekhova, H Stursova, Q B Truong, P Raymond, Y Sosnova, N H Khong, J Zarauza Navarro, C Florescu, L Gorshkova, N Saaidin, E Gordillo Higuero, L Davin, I Budanova, C Lavicka, L Gruznykh, P Bogdański, A Dufka, I Arroja, H A R Tahir, G Wilson, G Kolios, S J Yoon, Simon Cattan, K Berdnik, A Serrano, B Sievers, A Rodríguez Almodóvar, L A Holden, F O'Reilly, D Verleyen, H Hafez, K Nehrig, S M Kang, S Berrisch-Rahmel, E Meyer-Michael, P Samama, L Soares, A K Nguyen, F Tuktarova, C Weytjens, E Sandoval Rodriguez, J Cheng, F M Villasenor, João Morais, B Sullivan, R Zimoląg, Albert V. Smith, S F Ding, J C Louchart, G Guardigli, R Furtak, P Azzolini, S Chushak, J L Delgado Prieto, S Kornienko, K K Sia, J H Shin, F Baylac Domengetroy, P Błaszczak, M Saade, N Černič-Šuligoj, K Coetzee, A Kadleckova, V Scollo, O Larina, R Pal, M M Singh, N Nosova, R Burns, B S Yoo, O Gukov, F Massari, V Antia, A Brattström, G Holt, M Scherbak, V Firastrau, Y J Li, E Mikhailova, L Machado Cesar, C García García, J Pjontek, C Everton Biglow, G Pes, C Brown, A Bumbu, S Felis, R Bosch, M Lazaro, Luigi Tavazzi, R Engel, I Romeo Castillejo, Y S Byun, F Matias, I Grushetskaya, C Mestre-Fernandes, T Kheliya, S Schlesingerova, G Theodorakis, I Tsamopoulos, R Pedretti, A Puente Barragán, M P Vo, B Lammens, T Carruthers, J S Bhatt, A Khodanov, N Pasechnaya, I Petrova, G Boutros, I A Khan, E Le Moal, D Garofalo, H R Malaterre, A Bahal, J F Martínez González, H N Dinh, N V Pham, C Barjhoux, I Gilmour, C Soriano Navarro, O D Chioncel, K Tóth, N Borodina, P Khanoyan, B Sevilla Toral, H H Kim, C M A Bui, C Dernedde, N Eliseeva, M Galinier, E Kosachek, M M Doohan, L Potapska, M Tennekoon, R Nourallah, L Perez De Isla, K H Chee, E Panova, D M Walker, G Glanowska, G Hua, A Silvestre, W Wang, Matthew A. Brown, B Luke, G Jarosiński, R Davis, S Cleron, C Liatas, I Orestis, M Dereń, J Sudnik, S X Zhou, J Fuertes Alonso, O Baranova, S Mingalaeva, T N Vo, K A Ngo, J A Rodríguez Fernández, R Ishmael, G Bode, K K Chan, G Al Radaideh, S Ramphall, H D Theron, V Montagud Saavedra, A Yusuf, G F Mazzanti Mignaqui, L Evtukhova, J Lorenc, D Beacock, O B Šlapikienė, F Alitto, J N Poujois, B Berzal Martín, M Felbermayer, V Mallamaci, T Spitsina, R Ramachandran, A Jánosi, V Dženkevičiūtė, S Gillam, V Joulie, G Esna Ashari, R Henry, E Durand, A Alam, V Fourchard, H Dreycopp, R Fressonnet, C Camossa, O Jerzykowska, M Castrucci, G Sinicropi, B K Goyal, V Vasylenko, R Grogono, M Partington, B Vaquette, R Blindt, Mª T Moreno Casquete, V Kukaleva, W Streb, P F Clavette, M Pérez Paredes, V Hadjiivanov, C Bundy, D E Manyari, A Wassef, J Kuchar, W Nisker, P S Bath, S Panpunnung, G H Choo, Datshana P Naidoo, Y Pavlova, R McManus, N Brand, E Davies, L Prunier, A Schenowitz, P Sternthal, T Sinotova, J Martínez Florez, R Sykulski, J Pinar Sopena, M Balbi, Y Pesant, D A Playford, C Villar Mariscal, F Redding Escalante, W Wongcharoen, O Grechishkina, A Girão, M Speth-Nitschke, K A Mahendran, A Bianco, A Vadavi, G Singh, L Petoin Peuch, L Sukhanova, A Y Y Fong, J L Vega Barbado, A Dzien, S Honorat, G Ansalone, G Kamensky, G McLaren, T B Kim, I Bratu, R Fillet, V Rogozhyna, L Nagy, M Malgina, M A Sheikh Abdul Kader, Z C Li, L Rotaru H Rus, D Adamczyk-Kot, J Estrella, S Serrano García, P Farto E Abreu, D Mescharekova, Su Thillai Vallal, P Seal, S Möller, A Cziráki, T T H Ta, S Davies, H Ge, M Arafah, M Ovize, A Olszewski, V Aboyans, C Roche, F Al Tamimi, L Popova, V Kazachkova, R Rennert, J Aubry, G Bourgeois, J Mackrell, F Al Kandari, N Reifart, J Bérubé, W H J Hutse, O Lysunets, I Butkuvienė, J Cotroneo, J Gdalia, J Dalle Mule, R Santos, B Singh, H Mohammed, A Birkenhagen, T Chiscaneanu, H Sullivan, Jacob A. Udell, N Bolotova, A Jankowska, M Skonieczny, B S K Ch'ng, O Aiyegbayo, S Ciaroni, N Lago, S R Coimbra, R Ellis, B K Koo, S Rostik, P Jacquier, A Conradie, N Biryukova, M Ayche, A Khripun, B Peperstraete, E Velasco Espejo-Saavedra, G Cunliffe, G Grollier, C Ceraulo, T L To, Q H Tran, M Anscombe, R Jordan, I Czuriga, P Haimes, R Ancín Viguiristi, H Q Zhang, C A Chételat, A Rafter, E Rinkūnienė, K Yang, W Gao, J Pearce, L C Fernández Léoz, L Gareeva, R Fernández Alvarez, G Verret, P Astrakhantseva, C M Chu, L Murphy, P A Do, J L Liu, A Clifford, K Woollard, N Dmitrieva, N Lousada, R Díaz Juárez, N Semenova, T Fesenko, F Henschel, R Amini, G Matuszewska, R Christodorescu, J Varaldi, S Varughese, V Lafarenko, A Ashford, J L Colomer Martín, S Assouline, H Noor Hasni, A Weatherup, T Forster, R Kaserbacher, I Caldwell, N Arabadzhi, Emmanuel Sorbets, A Rink, E C Rueda Calle, J M Stordeur, P West, V C Do, Béla Merkely, J Antunes, U Altmann, S Magheru, B Bachmann, W Parkar, M de los Reyes López, M Wazana, A Frattola, M Mospan, V Koval, E Giusti Rossi, J Vasconcelos, K B Do, A Ogorodnichuk, D Lighezan, G Mentz, J M Cherry, P Pouderou, M Moretti, C M Spinu, Emmanuelle Vidal-Petiot, N Kupstytė, P Jourdain, V Voronina, O Varezhnikova, S Williams, H AlFaleh, R Lew, P Hildebrant, J Drozd, G Muscio, T H Ashton, A Achilli, J Harinasuta, T Ghose, G Walawski, Y Arkhipova, M Alves Costa, B Day, A Suntinger, A Singh, P Sheringham, A Vázquez García, J Taggeselle, J T Dong, T H Goh, G Rojas, R Schultz, A Ballet, O Likhobabina, Z M Qian, S Sandoval Navarrete, D Manzi, S Langridge, W Haerer, C K Abdullah, L Hay, Á Herdade, A Gałuszka-Bilińska, F Biausque, V M Lai, D S Eccleston, L Nikolaeva, P Kalaras, J Martínez Redding, N P H Tran, B Wauer, Philippe Gabriel Steg, B Etcheverry, J Navarro Manchón, R Augarde, C Dixon, M Y Chen, J L Gleizes, S Pustovit, J L Farges, S Cox, G Manchet, K Shein, L Parker, C C Ang, O Sinyukova, V Veth, A Kurekhyan, N Cindea Nica, N Wittlich, J Al Yazeedi, A Pucheu, V Elliott, J Bories, K Alford, M F Ferrão E Vasconcelos, A Adamkiewicz-Piejko, R Cervenak, J F Beltrame, A Castro, L Safonova, G Koutsimpanis, C de Brito Vianna, R Wysocki, V Ginzburg, J Hernández Afonso, A Ihonor, O Golubeva, M Karachaliou, S Kleta, D d'Este, Gustavs Latkovskis, F Jäger, E Gamzatov, Y Kozhelenko, J Lippai, T T L Ong, S J Ge, A Hersi, K Kyd, S Mingam, V Yordanova, L Bardachenko, E Mozerova, S W Liu, J Zdrojewska, E Chung, M Leclair, M Nazir, S Zarechnova, A Rahman, M Sołtysiak, B Maguire, F Moreira Pinto, R Fathi, E Prieto Moriche, C Priftis, P Heno, N Sytilina, A Pladys, S Shimonenko, P Keller, J F Junior, G Amiel Oster Sauvinet, J P Kanner, L Tkachenko, J Dalal, A Liston, D Herrera Fernández, J L Bonnet, A Chirivella González, R P Shah, F A Reyes Cisneros, C Avgerinos, P Ravoala, V Albero Martínez, G Suarez, V Jouve, A Frankiewicz, A Lindsay, A De Meester, H Dau, M Pornin, J Álvarez Gil, J Murin, T Hodac, J J Gómez Barrado, Y J Wu, S Jean, P Hilti, A Dayani, R Steponėnienė, G A Somsen, H Zhang, J Moore, P Tarenidis, T H Nguyen, M Maliszewski, L Voloshyna, S Novo, A Phrommintikul, I Shanina, Roberto Ferrari, P Franklin, C Turner, W Boonyapisit, F Sepulcri, P Vandergoten, J Carvalho, J Halcox, V Rotenberger, J F Baril, M Turiel, P Shiels, P Painsipp, S Reis Monteiro, T Honsig, V Vivekaphirat, J Ardill, P Brodzicki, A Khalifa, H Audibert, T Wettstein, F Auhser, D Ezekiel, D Pella, E Simarro Martín-Ambrioso, H S Seo, J A Núñez Gamero, Gabriel Steg, M Orbán, S Bykovskaya, W Gadziński, N Rozkova, G H M Vawda, R A Motyer, B Limeres González, E Fernandez Valadez, Riyaz S. Patel, I Shaikh, E Ziak, A Estriga, P Dodemant, Dragos Vinereanu, W Miao, L Marullo, F MacNamara, S K Tan, N Giacomantonio, A Leherissier, H W Li, Arpana Agrawal, Y Moreau, F David, S K Ma, A N Jamaluddin, E Alegría Ezquerra, Scalzo, M C Ta, T T Nguyen, A Sudre, R Gupta, H Lagioia, M Haiba, P Kohan, M Szentivanyi, T Dmitrieva, N Vechtomova, C Vuille, R G Schena, P Navratil, O Tsygankov, L Saaby, P Lefebvre, S King Wong, S Maheas Morlet, N H Pham, P Bonnet, S Modi, L Gaspar, M Karlicek, S Pallie, H T Pham, S Abele, N Bizyaeva, L Facila Rubio, N Meneveau, G Poluyanova, J Calaça, S Orazi, M Emonts, A Yusufali, V Sprott, Z Vazhdaeva, M R Conte, E Bulakhova, K Giokoglu, E Page, E Kotova, G Maragoni, C Jerjes Sánchez, T Kiver, M Brunehaut Petaut, A Nagy, P Singer, Zs Sziegl, B Fontanet, S Strange, A Watson, J Föchterle, Janet A. Dunn, R Šlapikas, M Stikhurova, S Salimova, J Volmar, E Otero Chulian, S Hutchinson, R Koller, X Bonnaud, E Peris Domingo, F Marín Ortuño, E Galve Basilio, S Bongo, L Payot, C Miller, A Samothrakitis, L Silva Melchor, K Orzechowski, W Hofer, L V Nguyen, R Oliver, K T Jung, J Robb, D Sobczyk, J Muller, A Tomatti, M Gruchała, C Bradshaw, D Richmond, E Mineeva, E Smirnova, A Idrissi-Sbai, H Vial, R Balai, I Kiseleva, H Jones, M Gibbs, D Ohlmeyer, Y Al Wahshi, V d’Alessandro, S Pérez Ibiricu, V Zachos, A Chernozemova, D R Spink, J Schneider, A M Peset Cubero, M Irurita Latasa, M Migliore, G Perna, E Daniels, M H Tay, N Z Khiew, I Soin, F Bernasconi, T Garban, F Omardeen, O Rodina, L Kanagaratnam, I Blum-Decary, A Jaussi, D Romero Alvira, D Vermander, N Kanumilli, M A Romero Maldonado, M Fernández-Valls Gómez, H Tran, T P Nguyen, H Omar, R S Collette, B Kisjós, H Krause-Allmendinger, J Silva E Sá, H Topf, F Panetta, T C Do, G Roul, J Leso, A Lacroix, M Fic, C Hart, R Chan, L Lema, Y Polyanskaya, R Howlett, Lesley J. Burgess, X P Chen, Hywel C Williams, V T Le, N Gurianova, R Duchowska, V P Nair, D Mitropoulos, A Allcock, T T H Bui, M Golub, E Yakovenko, M Perry, F Belcastro, K Svolis, B H R Forge, F Fernández de la Cigoña, N Murga Eizagaechevarría, G Mariano Pêgo, V Mincheva, T N Nguyen, J Moyal, M Wei, H Vinhas, A Batalla Celorio, C Romero Menor, S Rahman, N Hassler jun, F Duclos, K Ladha, A Ordóñez España, B C Chang, R Cortés Sánchez, G Lafrance, I Mihailova, Y Riou, I Pashentseva, S Tantillo, U Casas Juarezy, Ian B. Wilkinson, MJuneja, Q L Liu, M Baquero Alonso, P Kirmond, A Stevens, T Bouvy, P Casas Giménez, G Kassianos, P Kohler, T Rundell, J A Romero Hinojosa, T Sagastagoitia Gorostiza, M A Bennouna, A Hourany, F Thoin, G Steurer, V Batushkin, L Kolevatova, A Földi, G Sabe-Affaki, J T M Geraedts, I Illushechkin, T Korotich, W Manlay, B Merian, G Morrison, Y Wang, G Solache, P Magnus, A Lugin, S Tereshko, Jorge Escobedo, D Sharp, A Thelemann, J Gold, M Catarino Carvalho, P Lang, B Hermellin, B Doucet, A Martín Santana, E Foltzer, J Mora Robles, A I Bakbak, G Stanciulescu, L Baurenski, O Demina, G Lalljie, N Shmakova, R Vicente Amato, N Q Nguyen, S Kimmel, J-M Grégoire, F Tumarov, R Cue Carpio, S Nikishina, A Mukhtar, J Rueda Soriano, M Gnädinger, Michal Tendera, P Raska, S Cicek-Hartvig, E Potapova, A Melero Pita, P Ormiston, L Pastor Torres, R Shaw, M S Chenniappan, T Guo, L Zharikova, R Amoretti, J Janssen, G Kositsina, S Rajendran, N Atamanchuk, V Plastiras, T Kiernan, M H Pham, V M J Jelinek, J Dalrymple, S Van de Walle, M Goethals, I Stelmakh, S Cantabrana Miguel, L Hurlock-Clarke, C Ferreyra Solorio, J Alcaravela, H H Chuang, C Statescu, T Ługowski, B G Vanhauwaert, E London, G Z Pan, Z Özkan-Rashed, F Fellous, O Fillipova, K Ashmak, L Sargento, N Starostina, J A Ortiz de Murua López, H Thomas, T Gerasimova, L H Gowdak, S Perings, E Gaxiola, K Walcher, O Pogrebna, T Stasiuk, J Bell P McNaught, J Upton, G Scott, P Rossi Sevillano, A Gillet, T K L Nguyen, L E Manautou, L Kardashevskaya, A B Syed, F Brumelot, E Il'ina, V Alekseenko, G Wehr, G Gerges, B Fitzgerald, M Castellari, I Bratishko, M Dorobantu, I O'Connor, M V Ivan, A Esenokova, M Z Abdul Wahab, S Sylivris, S S S Quek, P Buffet, L Thomas, S Darnes Soler, N Pelicano, B Truong, N Vyshnevaya, M Habab, J Moreira, S Z Lv, D Shukla, P Eavis, E Kryvenkova, S Hansone, S Tabet, M Adda, R Trambitas, L A Fernández Lázaro, M Basara, R Mažutavičius, B Roy, X Dreyfus, T Karaseva, R Tilluckdharry, K Królicka, A Rogowsky, A Rodríguez Fernández, S Junejo, H Ancliff, W K Son, G Bodur, G Pournaras, N Sharapova, J Egido, S Kuanprasert, E Alexanderson, L Vanneste, L Singh, N Bokuchava, D K Jin, E H M Tan, A Bernard, F Baslaib, M A Fazil, M Deissner, F Narro García, R Bonhomme, A Dan, V S Hoang, R Snikytė, O Ratovskaya, T T N Pham, M I Mendonça, F Bates, N Karnaukhova, P Nazeyrollas, L A Elizondo Sifuentes, D Onger, S Yakovova, R Sadłowski, B Doronzo, J Carda, A Taylor, A Albuquerque, V López Mouriño, I Segura Laborda, D O'Donnell, R K Pandey, M Asplanato, M A Paz Bermejo, E Rodríguez, L C Iosipescu, K Fikker, Y Porras Ramos, M Escande, D Binet, J Mantoux, P Barahona Pérez, V Zakirova, A Rocha de Lorenzo, I Konstantinidis, H-H Breuer, B Hockings, A Muthu, Koon-Hou Mak, A Soward, D D Ionescu, P Talbot, F Patriarchi, A Meinel, S Abdel Malak, E Craiu, N Ranjith, B A Lim, R Rosado Soares, G Barauskienė, J Vercammen, N Shelomova, S Govender, S González Romero, K S Ng, D M'Bey, B Al-Khalidi, J Berlingieri, J B Fournier, J Tan, P Mochkina, S Pouwels, G Caridi, D P Phan, P Soskin, D Farcas, C Constance, D Rouse, A Tudose, J M Yu, T T C Nguyen, R Brownlie, J Giordano, A Gigantino, T Yip, A I Noury, R Baroudi, E Pinch, I Landragin, T Cahill, N H Mohd Amin, S Baptista, V Lavicka, P Rodenas, M Jeserich, K F Alhabib, U Teleky, M Ege, D Bierge Valero, D Kozlov, M Vallis, A Rahali, F Maes, E Guiu, P Hutayanon, C Escobar Cervantes, H D Luong, T Salah, J C Ford, C Travill, G Barron, L Rebelo, A S Abdullah, K-H Schermaul, Z Lorenc, F Perreault, O Shamsutdinova, A Fernandes, H Rickli, E Usoltseva, C Cazenave, N Baboshina, P Matthews, N Schön, W Matta, J H Zo, N Pontaga, E Novo García, G R Searles, J A Wang, M S Grocutt, A Kondratovica, P Povolna, J Arnedillo Pardo, J L Prevot, J A Rodríguez Hernández, H Killat, M Hinrichsen, S Santaolalla Rodríguez, F Calvo Iglesias, P Mpompoth, M Claus, K Kunhali, K Panisois, A Lourenço, D Iovescu, I Simkova, C González Juanatey, A Vicentini, C Baranes, J Hilario Jiménez Orozco, M Magherusan, I Orpen, M Horrigan, M Banu, R Weinrich, C Arsenescu Georgescu, R Dubinskaya, Y Kulikova, C Petrillo Pio, N Khishova, R Mika, P Dalampyras, M Maćków, M H Custódio, M A Cobos Gil, Y D Chen, B Bondarenko, V Puel, S Garg, Y Lemiere, J Bruguera Cortada, A Pereira, C Vaticón Herreros, V Ravlyk, G Pons, E Osadchuk, Dayasagar Rao, O Charikova, E Liu, M Baverstock, V Kulygina, J P Dubs, V Climent Payá, M Grobéty, I Krajnc, I Feldmann, A Idoate Gastearena, F Paillard, M Alanbaei, D Sinclair, F Pitella, M Casanovas Pié, R Sheahan, F J Nasser-Sharif, M Goralski, D Kinloch, N Chauhan, M Sandin Rollán, M Didier, N S Pham, W Heddle, N Oleinikova, E Verbrugge, C Amo Fernández, M Kraus, Y K Chan, A M Kushner, K Phillips, V Barriales Alvarez, V Martins, P Talavera Calle, Y Jobic, P Túri, C Greco, G Scalia, J Flores, P Saul, C K Wong, O O'Toole, S Nurgalieva, K Makarenkova, S Hayne, S Kutuzova, N MacCarthy, D Logan, J M Dubois, J Cygler, M Kindel, V Karnot, T Herbots, G Masszi, J de Jesús Rivera Arellano, C Botana Penas, T Vicente Vera, R Karnik, J Morales González, L Lasalle, A S Sahar, R Forrai, A Shekhar Pandey, T Wang, N Maximchuk, A Chung, D Zalewska, O Bashkirtcev, A O'Gara, E Dubinina, H E Harlos, P Meyssonnier, G Dalton, X Tabone, R Capalneanu, I Soosiwala, J Finlayson, H Soleille, T J Hong, I Myhailiv, K Babes, K Modzelewska, Robin Young, K Mayr, J Freire Corzo, J M Bourgeois, S Guerard, F Fernandes, A Loera Pinales, C Schmied, A Minsafina, J Ingham, J Escobedo de la Peña, Y Guo, C Krasucki, R Gendreau, J Bonal, I T Ly, M Jaquet Herter, W Kępa, B Prasad, J L Zamorano Gómez, S Banham, P Ziehn, Nicolas Danchin, C W Goh, M Gonzalvez Ortega, D Dymova, P Bishop, T Dutoya, J E Poulard, P Monnier, O Si, J L Briseño, G Attia, N Khartova, I Gorlova, L Raisova, B Faudon, V Freeman, M Kerbev, U Frank, G Kaliska, A K Ghapar, C Tricot, L Jankowska, V Dormagen, A Pasquet, I Kruglova, P Chemin, J L Díaz Díaz, J H Tao, R Bietzk, G Sceats, K Lai, P Berthezene, Digna R. Velez Edwards, A Buakhamsri, N Bazargani, U Spengler, M Toringhibel, M A Matos, I Skoczylas, V Arrarte Esteban, J Fuertes Beneitez, V Gil, L U P Tran, A Mehta, A Álvarez Sangabriel, P Di Pasquale, K Egstrup, P Choudhury, S Whetstone, T S Chee, M Elkohen, P Martina, J Martínez Rivero, C Arden, J Walczewska, I Benett, R Silvestri, V García Saavedra, J Słaboszewska, A Thomson, S Revienė, A Szpak, V Challenor, F Saporito, P Ruiz Pérez, Vives, H M Li, I Sadykova, D Lawton, T Kuzmina, R Elias, D Troup, P Dehayes, J Vavougios, V Pernice, P Tanielian, R Cabrera Solé, T Pitsch, R Nethononda, P Poinson, A Tavares E Taveira, J Yi-MingCha, J Y Hwang, T Haghfelt, C García Pindado, N Bilous, A Kotsalos, M Bariaud, A Drzewiecka, L Polkina, V Arfaras, P Vymetal, J Rawal, A Aumjaud, H P Wang, L Wu Amen, J Fernandes, F Howie, A Ouguoujil, M H Ngo, J A Bertarini, A Malysheva, G De Geeter, N Aimouch, R Parkin, H Taylor, M Kittipovanonth, A Gupte, S Ramanaidu, L Basto, A Zherebtsova, T Arsentieva, V Männl, Y L Cham, J J Gómez Doblas, D Ennouchi, Iveta Mintale, A Vance, R Jirmar, L Boikova, D T Le, P Srivastava, L Tonet, M Liautard, C Proto, Q H Do, Mª A Pérez Martínez, R Stankevičius, L Semedo, M Anghel, I Nikolaeva, J Janes, H Al-Backer, M C Escourrou Berdou, O Leshchuk, D Reshotko, V P Dang, I Édes, L Schlueter, B Sikorska-Buczkowska, K Hatalova, I Marozsán, S Gessner, J Gmehling, M Kuzmicheva, Z Huang, L Kosareva, D K Kumbla, A Baika, F El-Shaer, T Voronova, J M Chopo Alcubilla, A Veternik, S Mohr, D Garcia, J Y Rhew, C K Yeo, C De Niel, H K N Nguyen, E Orts Soler, J Dubrava, S Natarajan, M S H Khan, U Kossowska, J P Detienne, T T H Nguyen, I Centa, M G Millauer, Jose Lopez-Sendon, J T Counsell, E Galehr, T Schröder, L Frost, P P Singh, C Moya López, R Beyer, L Carpentier, J Carrillo Calvillo, Z M Du, R Steeds, E Horstkotte, P Kindler, P Johnson, M Sander, I Rodríguez Tejero, F Azar Manzur, S Brown, M Odín de los Ríos Ibarra, C K Choor, M A Sadiq, D B Gysan, V B Doan, A Gueusquin, M Andrews, L L Feng, B Martina-Hooi, S R Shetty, Y Dascotte, E T Ch'ng, P Dematteo, A Woodall, S Gabriilidis, Jean Ferrières, S K Oh, J Lindford, S Blignaut, L Macedo, R Carrillo Cardoso, Y C Lai, C Lang, S R Jayasinghe, B Bastian, V Sanfins, J de Jeús Zuñiga, F X Meriaux, G Sepp, S Molotyagina, S García Ortego, T Perger, Y Lukina, J H Wirtz, A Regulska, P Durand, P Loheac, J Sinnadurai, S Avlonitis, J García-Moll Marimón, J Bradley, K Pareathumby, L Latyntseva, D Stergiou, K Ling, S K Hong, N S Chonkar, C Goldie, C C Koo, A Salustri, Y Peneva, I Rodríguez Briones, P Ferreira, L Franskyavichene, G Bragança, C Rodrigues, S H Lee, L Dang, B J Lubelsky, L Weinrich, E Hoffer, J Tricoire, M Marachli, O Smirnova, C Falces Salvador, A Mobeirek, M Fagan, A Serazhim, M M W Yeung, F Petitjean, I Cullen, J Benacka, Yañez Wonenburger, D Gentille Lorente, J Ferreira Dos Santos, F Bosa Ojeda, N Marchionni, L Brottier, P Keelan, D Kerö, L Moretti, R Seabra Gomes, I Jasinkevica, P Purnode, D Relange, H N Luqman, A Petit, I Hamilton-Craig, E Kochurov, P Berry, P Aguar Carrascosa, M Noble, S Yvorra, N Razzaq, J M Walch, L Lenartowska, R Sethi, W Kim, C Killeen, S Kurochkina, N Capuano, P Sampson, K H Mak, T Bouchaya, J Hellermann, M Geneves, F Ramos Ariznabarreta, J L Mougeolle, J Ferreira, T Roy, J de Andrés Novales, J F Monteiro Ferreira, M S Mayer, N Lopez Cabanillas, P Touzet, K H Ng, F Pelier, T K Huynh, J Schindler, T Krechunova, A Gaglione, Z Fras, P Haralambus, R Pradhan, L P Low, G Odent, M Sidor, R Sopia, D Janody, T K Ong, K Adamaszek, G Vives Boniato, T Maxwell, H Charles, D Gough, O Dibon, A A Abdul Rahim, H B Liew, S Tikhonova, I Bläse, J Chambel De Aguiar, E Santas Olmeda, M Rosseel, R Angela, D Savard, C Cernetti, O Huttin, J Calder, O Kilaberiya, A Elkrail, I I Tulevski, A Ilyukhina, E Chalkiadakis, R Antonicelli, H C Gwon, G Bautista López, G Brown, J Kojelienė, R Zeitouni, J Mimoso, N Better, N H Vu, H Abdel Wahab, B Poprawa, F Weber, A Ghicu, K Rybak, G Fouquet, C Pindado Rodríguez, A Salakhova, L Isaeva, M H Fallacher, J Placke, G McCansh, V D Tran, O Gusev, D Enayat, P Khera, E Brice, G Levesque, A Alvarez Auñon, M A Arnau, M A López Aranda, E Andreicheva, I Kruck, R Grigoriu, I Sainz Hidalgo, M Węglarz, A Ajani, I Khudina, T Makhieva, V D Dang, R Testa, E Cisowska-Drozd, F Giacomazzi, R Cierpka, Nicola Greenlaw, P Wong, L Simões, L Tsaryabina, O Gureeva, R Raffelsberger, H Luquez, A Rainbird, D Evéquoz, M A Balice-Pasquinelli, R Massay, K L Joseph, I H Chae, R Herrmann, I Salecker, A Montero Gaspar, P F Fonseca, A Martin, W Czarnecki, R Motomancea, E Dechoux, M Shamsuzzaman, M Leandri, D Marzal Martín, C Navas Navas, C Beaurain, T Gkinis, K Shetty, P A Jeannerat, D S Wong, A Gonzaga, W Kulig, J F Millet, E Jankauskienė, E Anastasiou, A I Ruhani, N Aksyutina, O Kolesova, K Yared, M Panajatovic, Y L Zhou, S Thurston, T Alekseeva, S Preston, N Mai, M Kuzyakina, D Rechtman, T Boonyasirinant, J Nobre Dos santos, A Ahuad Guerrero, M Al-Shamiri, M Feldner-Busztin, S Godart, S Liandrat, A Narayan, L Burlakova, M J García Martínez, C Militaru, J Chávez Paez, H B Matheson, D Meddah, P Brindle, N Petrova, A Nicolino, D Spensieri, A Giuca, E Molina Laborda, J Moreno Arribas, V Martinho, T Mularek-Kubzdela, S K Chua, G A Dan, N T H Tu, V T Nguyen, M Alcocer Gamba, J Costa, H Milligan, R Badr-Eslam, E Variava, A Merkhi, C Mays, R De Castro Aritmendiz, A K Mohamed Yusof, A Hamer, R McNeilly, S Dedkova, D Rousson, K Chamou, A Mahr, D C Dan, R Till, T L Yang, M Vida Gutiérrez, D Piyayotai, É Bajcsi, D Zaronskienė, I Alexopoulos, Y Huo, H S Zeng, P Rowe, S Fleming, D B Vu, Á Dongó, C Hand, J C S Leong, M Claeys, S Hood, J Bozkova, G Vieyra, G Unger, A Liqui-Lung, D Cremer Luengo, M Castillo Orive, S Muth, M Joseph, P L Torres Díaz, C Zakopoulos, D Cross, F Trujillo Berraquero, F Sattar, H A Boyrazian, T B Le, M Mantcheva, M Constantinescu, P Gosse, U Keil, G F Vaz, M Bdeir, T S Pham, M J García González, J K Ryu, D W Jeon, Zs Malkócs, J Á Perea Egido, R Izquierdo González, V Probst, E Wellenkamp, C Boureux, M Czarnecka, C Vaughan, H Falconer, H Brunner, G Peña Pérez, E Nelböck-Huber, E Blanc, F Thomas-Richard, A L R Ng, M Provvidenza, R Gascueña Rubia, J Freitas, A Dabboura, B Mörz-Proszowski, A Utech, C Alves, C M David, J A Lastra Galán, L Oliveira, T A Nguyen, I Ghaly, A Hofmeister, I Gorodilova, P Szałkowski, M S Hiremath, G Golovina, C Daly, M Tardy, S Kostomarova, J-P Salembier, P Zagožen, D Wang, M Vogel, J Borbola, I Chlewicka, K-H Schmitz, C Pappas, J Victory, M Garandeau, P Wiggers, C Piñero Ramírez, L Tkhorzhevskaya, E Suglobova, V Samakhovets, P Surmont, H A Ramírez Reyes, M Winter, F Prunier, B Cavert, B Salaun, J M Roca Catalán, A Beinhauer, Ian Ford, K Elsby, V Knyazeva, C Tamburino, V Khoury, A Felice Castro Issa, B Marchenko, K König, A Kennedy, J M Alegret Colomer, T Gillet, Clarify Investigators, B Maheu, A Troncoso Gil, N Haldane, B Koujan, T Mouhat, A Waldman, J Robert, J Campbell, A Kokis, M Micheals, P Gori, P Ramoutar, M Al Zaibag, V Ryzhkova, M Kazakovtseva, C Bernardeau, B Ferreiro Rodríguez, Y Voloshko, S Szabo, I Jarvis, Y N Ke, J Donetti, A Serrano-Garcia, R Ketelers, S Grigoryan, V Kulik, P Zündorf, L Kleemann, J McPherson, M Luaces Méndez, F Mouquet, L G Xiong, T H Tran, P Costello, A Potter, M Cinteza, F Colivicchi, E Nowicka, O Greiner, G Reddy, M Martins Oliveira, F Fernandes De Sousa, P Nocon, R Sewell, I Nikodemska, R Tadeu Munhoz, T Gilbert, I Laizane, M Maroun, B Demianiuk, A Bolidai, R Kacorzyk, R Fernández Mouzo, K Karastanev, J Blanco Castiñeiras, P Messali, R Schwarz, M Vardhani, O Gouli, C Thelemann, A Forclaz, G Khaznadar, G Eisele, P Sosner, M L Bourachot, N Pontikakis, S Heinemann-Meerz, E Zatsarina, E Smrckova, P Calmettes, D H Kang, M L Santos Iglesias, S M Marinescu, A Heap, Melnikova, N F Strathmore, S Tolpygina, M Yang, M Naisseh, E George, J Banach, E Delcoulx, E Teijeira Fernández, J Poles, P Saunders, S Haddad, T Q Luu, A Dhesi, O Prikolota, M Baar, P Lafontaine, C O'Dong, I Petropoulos, B-M Altevogt, D Warden, T De Backer, G Miñana Escrivá, T L Mai, U Schlesinger-Irsch, M M Gomaa, E Moksyuta, M Drexler, P Monteiro, P Grooterhorst, J Moolman, P McAlavey, J O'Shea, L P Quinn, F Crespo, K Srinivasa Reddy, T Shokina, Ellen M. Schmidt, M H Jeong, K Denef, A Pleskof, I Takács, Y Tikhonov, O Ushakov, L Stevens, J Ezcurdia Sasieta, L Nkombua, O Henne Otero, J Y Fraboulet, D S Kim, G Hoh, A Tamm, M Sardon, G Chatzioakim, M A Ulecia Martínez, S Reymond, M Myint, G Proença, R Massabie, E Foster, H Dougall, Anjan Kumar Roy, C Franco Aranda, M Getman, E Filippova, C Aguiar, X D Pu, N Voronina, L L Chen, M Szulc, L Bayakhchan, M J Pinto Vaz, C Niederberger, N Vites, I Sen, Paul R. Kalra, J A Castillo Moreno, W K Ng, C Brunschwig, D Morgan, A Concepción Clemente, N Yakimova, J M Guy, A H Jaafar, J Badarienė, N Taylor, L Compson, R Amor, A Maximovitch, J L Bardají Mayor, E Marín Araez, N H Chau, N Srtumilenko, K Kelly, A Papathanasioy, S Erofeev, B Mamez, A Ribeiro, M Micko, N Alvarenga Recalde, K Atueva, Z Sebõk, P Kycina, A K Gupta, A Laucevičius, R Ahuja, A Prokop, P Stadler, S De Ridder, L Zhang, F B Ramadan, L Kapustina, V Fedoskin, A Bateman, C A Nacht, R Musetescu, M Aparici Feal, A Büttl, S Ross, M Rau, P Federico Zaragoza, G Brisson, M Zagreanu, T T H Pham, F Dominé, N Davydova, N Petrochenko, N Paul, P H Truong, S Frickel, W Bryl, G Brouillette, A Stumpp, M Barrera Bustillos, C Ziccarelli, O Zalyzniak, M eatherhead, N Watkins, G Riccioni, l Kudryavtsev, R Carvalho, J P S Sawhney, V González Toda, P Matos Dias, M Giorgadze, I Rodriguez Marrero, W Gritsch, K Lee, G W Kellam, I Parker, V Ecina, Mª I Soto Ruiz, C Delhomme, T Ivaschenko, Y W Cheah, I Grudtsina, R Chehayeb, T Dookie, O Krasnoslobodskaya, P Jarmużek, F Van den Branden, A M F Vandeplas, A Rocha De Almeida, M Espiga De Macedo, E Łotocka, K Nagy, R Paliulionienė, J L Leyva Pons, N Fedorova, Y Yanina, O Stasuk, Z Vlasuk, P Lim, P Egloff, T Berezhna, A Faria, J Cerda Rojas, E Moser, H G Jin, S J Oh, G Arquero García, K H Karner, I Leontaridis, A Banikova, J Fridrich, H Lesseliers, I Pokrovskaya, P Astridge, H Abdul Manap, R Daniel, C A Almeida Fernández, A Nowowiejska-Wiewióra, B Carvalho De Moura, M Malden, H Rosenstein, S Dixon, G Balogh, M Adam-Blanpain, A Sandalian, H Gervas Pavón, G A Antoniadis, N Naberezhnova, A Amlaiky, P Terrosu, K K H Lau, B Chartier, X Su, O Kovyrshyna, G Beale, P Primot, M H Chen, S S Ramesh, R Chyrek, E Gómez Álvarez, J Rodríguez Collado, G Sibilio, R Jeremiasz, R Colin, C Lalla, G M Fullerton, M P Samal, H Thümmel, R P Patel, J Takhar, H M Kwon, T A Cieza Lara, F Magliari, J Morrell, M Rayo Gutiérrez, T L Orenstein-Lyall, H Choi, S Kulinich, A Aftab, A Wallace, B B Abdul Kareem, S Kwok, A Królak, A Grover, Laurent Fauchier, Mª J Pinilla Lozano, G Sengupta, D Paris, M Al Dhanki, J Milewski, F Petersen Aranguren, H Brufau Redondo, H Mayr, A Arias Mendoza, M Ducoudre, A Correia, J S Awtar Singh, P Aylward, E Brscic, J Du Plooy, J L Arenas León, G Silva Alves, L Sreenivasa Murthy, P Dendale, F La Varra, S Minkin, T Eggeling, A Jamiel, G Lebischak, E Andreev, T V A Tuong, V Chaithiraphan, O Duprez, S Higgins, F Chometon, Y Cottin, A Bonny, C Guyetand, J Matos, F Henpin Yue Cesena, L Polyaeva, M Drijfhout, J Toplak, G E Vertes, N F Wang, J Doucet, A K Trivedi, P Turek, G Chouinard, A Al Lawati, W Filip, F Kovar, T J Cha, A Belanger, H L Cong, J F Robert, D López Gómez, J L Sanz Rodríguez, H Simper, P Shetty, A Chukwu, E Bukanina, C Amoros Galito, H MacCowan, T T T Tran, A Singal, K C Vu, O Ismail, A Ardiaca Capell, P Bousquet, F Goss, Z Galeeva, Maxime Guenoun, B Rijavec, Z Lazerevic, A McCracken, A C Motoc, Y Sharapova, S Wright, A J Paule Sánchez, L Mainar Latorre, I Sirazov, X L Yang, S E Paget, G Berkenboom, J Markenvard, I Surovtseva, S K George, Matthias Simon, M L Fuantos Delgado, C Christoforidis, M Lagares Carballo, P Alvarez García, J Könemann, L Crawford, I Gonos, D Saulnier, E Szabó, L Ardouin, J Bhayat, F J Abardía Oliva, X Bernard, O Sirbu, P Boutsikos, N Khmelevskikh, E Tavlueva, P LeBouthillier, I Bourazanis, A Sequeira, M López Martínez, C P Paulus, R K M Bhaskaran, F Pellerin, B Brown, B Saleh, A Lacchè, R Sola Casado, E Kaźmierczak, M Weingrod, and G Vijayaraghavan
- Subjects
medicine.medical_specialty ,Cardiac & Cardiovascular Systems ,Epidemiology ,LONG-TERM ,medicine.medical_treatment ,Chronic coronary syndromes ,Coronary Artery Disease ,Revascularization ,Ventricular Function, Left ,GLUCOSE ,MELLITUS ,Risk Factors ,Internal medicine ,Diabetes mellitus ,Diabetes Mellitus ,Ethnicity ,Prevalence ,medicine ,Humans ,ARTERY-DISEASE ,Myocardial infarction ,Stroke ,RISK ,OUTCOMES ,Ejection fraction ,Science & Technology ,business.industry ,Proportional hazards model ,CLARIFY Investigators ,Hazard ratio ,Diabetes ,Stroke Volume ,Geographical disparities ,Syndrome ,medicine.disease ,MIDDLE-EAST ,EUROPEAN-SOCIETY ,Treatment Outcome ,MYOCARDIAL-INFARCTION ,Heart failure ,CLARIFY registry ,Cardiovascular System & Cardiology ,HEART-FAILURE ,Cardiology and Cardiovascular Medicine ,business ,Life Sciences & Biomedicine - Abstract
BackgroundIn contrast with the setting of acute myocardial infarction, there are limited data regarding the impact of diabetes mellitus on clinical outcomes in contemporary cohorts of patients with chronic coronary syndromes. We aimed to investigate the prevalence and prognostic impact of diabetes according to geographical regions and ethnicity.Methods and resultsCLARIFY is an observational registry of patients with chronic coronary syndromes, enrolled across 45 countries in Europe, Asia, America, Middle East, Australia, and Africa in 2009–2010, and followed up yearly for 5 years. Chronic coronary syndromes were defined by ≥1 of the following criteria: prior myocardial infarction, evidence of coronary stenosis >50%, proven symptomatic myocardial ischaemia, or prior revascularization procedure.Among 32 694 patients, 9502 (29%) had diabetes, with a regional prevalence ranging from below 20% in Northern Europe to ∼60% in the Gulf countries. In a multivariable-adjusted Cox proportional hazards model, diabetes was associated with increased risks for the primary outcome (cardiovascular death, myocardial infarction, or stroke) with an adjusted hazard ratio of 1.28 (95% confidence interval 1.18, 1.39) and for all secondary outcomes (all-cause and cardiovascular mortality, myocardial infarction, stroke, heart failure, and coronary revascularization). Differences on outcomes according to geography and ethnicity were modest.ConclusionIn patients with chronic coronary syndromes, diabetes is independently associated with mortality and cardiovascular events, including heart failure, which is not accounted by demographics, prior medical history, left ventricular ejection fraction, or use of secondary prevention medication. This is observed across multiple geographic regions and ethnicities, despite marked disparities in the prevalence of diabetes.ClinicalTrials identifierISRCTN43070564
- Published
- 2021
116. Droplet digital PCR of tumor suppressor gene methylation in serial oral rinses of patients with head and neck squamous cell carcinoma
- Author
-
Kwan Chee Allen Chan, Jacky W K Lam, Eddy W.Y. Wong, Zenon W C Yeung, Ryan Cho, Sherwood Y H Fung, Jason Y. K. Chan, and Cherrie W K Ng
- Subjects
0301 basic medicine ,Tumor suppressor gene ,head and neck squamous cell carcinoma ,Polymerase Chain Reaction ,law.invention ,droplet digital PCR ,03 medical and health sciences ,0302 clinical medicine ,law ,medicine ,Humans ,Digital polymerase chain reaction ,Genes, Tumor Suppressor ,Liquid biopsy ,Promoter Regions, Genetic ,liquid biopsy ,business.industry ,Squamous Cell Carcinoma of Head and Neck ,Head and neck cancer ,Methylation ,Original Articles ,DNA Methylation ,medicine.disease ,Head and neck squamous-cell carcinoma ,stomatognathic diseases ,030104 developmental biology ,Otorhinolaryngology ,Head and Neck Neoplasms ,030220 oncology & carcinogenesis ,Cancer research ,Carcinoma, Squamous Cell ,Suppressor ,PAX5 ,Original Article ,head and neck cancer ,methylation ,Neoplasm Recurrence, Local ,business - Abstract
Background Head and neck squamous cell carcinoma (HNSCC) currently lacks sensitive approaches to detect cancer‐related traits in body fluid. Methods Methylation of tumor suppressor genes (TSGs) (PAX5, EDNRB, and DCC) were measured in the oral rinses from 50 HNSCC and 58 control subjects using droplet digital PCR (ddPCR). Diagnostic accuracies in detecting HNSCC and the detection rate of recurrence in the post‐treatment monitoring were analyzed. Results ddPCR TSG methylation detection in oral rinses for diagnosis of HNSCC had an AUC of 0.892 for PAX5, 0.753 for EDNRB, and 0.729 for DCC. Significant drop of TSG methylation was observed after completion of surgery (p
- Published
- 2021
117. The Knockdown of Nrf2 Suppressed Tumor Growth and Increased the Sensitivity to Lenvatinib in Anaplastic Thyroid Cancer
- Author
-
Jason Y. K. Chan, Xianhai Zeng, Alexander C. Vlantis, C. Andrew van Hasselt, Minghui Wei, George G. Chen, Dongcai Li, Zhi-Min Liu, Michael C. F. Tong, Zhongqin Gong, and Lingbin Xue
- Subjects
Aging ,endocrine system ,endocrine system diseases ,Article Subject ,NF-E2-Related Factor 2 ,Mice, Nude ,Apoptosis ,Thyroid Carcinoma, Anaplastic ,Biochemistry ,digestive system ,environment and public health ,Papillary thyroid cancer ,chemistry.chemical_compound ,Mice ,Cell Movement ,Cell Line, Tumor ,medicine ,Animals ,Humans ,Anaplastic thyroid cancer ,RNA, Small Interfering ,Receptor, Notch1 ,Thyroid cancer ,Notch 1 ,Cell Proliferation ,Gene knockdown ,QH573-671 ,business.industry ,Phenylurea Compounds ,Cell Biology ,General Medicine ,respiratory system ,medicine.disease ,chemistry ,Cell culture ,Cancer cell ,Cancer research ,Quinolines ,Female ,RNA Interference ,business ,Lenvatinib ,Cytology ,Research Article - Abstract
Papillary thyroid cancer can dedifferentiate into a much more aggressive form of thyroid cancer, namely into anaplastic thyroid cancer. Nrf2 is commonly activated in papillary thyroid cancer, whereas its role in anaplastic thyroid cancer has not been fully explored. In this study, we used two cell lines and an animal model to examine the function of Nrf2 in anaplastic thyroid cancer. The role of Nrf2 in anaplastic thyroid cancer was investigated by a series of functional studies in two anaplastic thyroid cancer cell lines, FRO and KAT-18, and further confirmed with an in vivo study. The impact of Nrf2 on the sensitivity of anaplastic thyroid cancer cells to lenvatinib was also investigated to evaluate its potential clinical implication. We found that the expression of Nrf2 was significantly higher in anaplastic thyroid cancer cell line cells than in papillary thyroid cancer cells or normal control cells. Knockdown of Nrf2 in anaplastic thyroid cancer cells inhibited their viability and clonogenicity, reduced their migration and invasion ability in vitro, and suppressed their tumorigenicity in vivo. Mechanistically, knockdown of Nrf2 decreased the expression of Notch1. Lastly, knockdown of Nrf2 increased the sensitivity of anaplastic thyroid cancer cells to lenvatinib. As knockdown of Nrf2 reduced the metastatic and invasive ability of anaplastic thyroid cancer cells by inhibiting the Notch 1 signaling pathway and increased the cancer cell sensitivity to lenvatinib, Nrf2 could be a promising therapeutic target for patients with anaplastic thyroid cancer.
- Published
- 2021
- Full Text
- View/download PDF
118. Retroauricular Approach to the Submandibular Gland
- Author
-
Eddy W.Y. Wong and Jason Y. K. Chan
- Subjects
medicine.anatomical_structure ,business.industry ,Medicine ,Anatomy ,business ,Submandibular gland - Published
- 2021
- Full Text
- View/download PDF
119. The Emergence and Epidemiology of Haff Disease in China
- Author
-
Thomas Y. K. Chan
- Subjects
Haff disease ,rhabdomyolysis ,crayfish ,China ,Medicine - Abstract
Haff disease is a rare syndrome of unexplained myalgia and rhabdomyolysis occurring within 24 h of consumption of certain types of cooked freshwater fish or crustacean. It is caused by a yet unidentified heat-stable toxin. In the present review of published case studies and official press releases, the main objective is to report the emergence and epidemiology of Haff disease in China. Haff disease first occurred in Beijing in 2000 and in Lianzhou and Liannan, Guangdong Province in 2009. Subsequent outbreaks mostly occurred in the Jiangsu Province—Nanjing, Yangzhou, Huai’an, and Yancheng. Isolated outbreaks occurred in other cities since 2010—Shijiazhuang, Yueyang, Shanghai, Wuhu, Baoding, Shenzhen, and Hong Kong (imported cases from Shenzhen). Outbreaks occurred predominately in the summer. Crayfish accounted for almost all the outbreaks. Two large outbreaks occurred in Lianzhou and Liannan in 2009 (n = 54) after eating pomfrets and in Nanjing in 2010 (n = 42) after eating crayfish. Other reports or outbreaks involved only 1–9 subjects (median 2 subjects). Variability in individual susceptibility and attack rates were noted, with many subjects remaining asymptomatic despite sharing the same seafood meal as the index cases. Adults were predominately involved. Symptoms occurred within 3–20 h of seafood ingestion, including myalgia, weakness, and, less frequently, nausea, vomiting, abdominal pain, and diarrhea. Myalgia and muscle weakness should normally subside within 2–3 days. Serum creatine phosphokinase became normal within 5–6 days. Abnormal renal function was uncommon. Serious complications (renal failure, multi-organ failure, and prolonged myopathy) and death were rare. In any subjects with unexplained myalgia and rhabdomyolysis, seafood consumption should be included in the history. All suspected cases of Haff disease, including milder presentations, should be reported to public health authorities.
- Published
- 2016
- Full Text
- View/download PDF
120. Herbal Medicines Induced Anticholinergic Poisoning in Hong Kong
- Author
-
Thomas Y. K. Chan
- Subjects
anticholinergic poisoning ,herbal medicines ,tropane alkaloids ,Flos Daturae Metelis ,Hong Kong ,Medicine - Abstract
In the present review, the main objective was to report the incidence and causes of herbal medicines induced anticholinergic poisoning in Hong Kong during 1989–2012 and to emphasize the importance of pharmacovigilance, investigations and preventive measures. Relevant papers, official figures and unpublished data were obtained from Medline search, the Department of Health and the Drug and Poisons Information Bureau. In the New Territories East (where ~20% of the Hong Kong population lived), the incidence of herbal medicines induced anticholinergic poisoning during 1989–1993 was 0.09 per 100,000 population. There were no confirmed cases during 1994–1996. In the whole of Hong Kong, the incidence during 2000–June 2005 was 0.03 per 100,000 population. Contamination of Rhizoma Atractylodis (50%) and erroneous substitution (42%) were the main causes. The incidence during 2008–2012 was 0.06 per 100,000 population. Contamination of non-toxic herbs (50%) and erroneous substitution (41%) were the main causes. In Hong Kong, contamination of non-toxic herbs by tropane alkaloids and substitution of Flos Campsis by toxic Flos Daturae Metelis were the predominant causes of herbal medicines induced anticholinergic poisoning. Systematic studies along the supply chain are necessary to identify the likely sources of contamination. If erroneous substitution of Flos Campsis by Flos Daturae Metelis could be prevented, 40% of herbal medicines induced anticholinergic poisoning would not have occurred. Regular inspection of the retailer, continuing education for the staff in the herbal trade and repeated publicity measures will also be required. Pharmacovigilance of herbal medicines should help determine the incidence and causes of adverse reactions and monitor the effectiveness of preventive measures.
- Published
- 2016
- Full Text
- View/download PDF
121. Profiling severe acute respiratory syndrome coronavirus 2 and its relevance to otolaryngologic examinations during the coronavirus disease 2019 pandemic
- Author
-
Catherine P L, Chan and Jason Y K, Chan
- Subjects
Aerosols ,Infectious Disease Transmission, Patient-to-Professional ,SARS-CoV-2 ,COVID-19 ,Oropharynx ,Viral Load ,Ambulatory Care Facilities ,Infectious Disease Transmission, Professional-to-Patient ,Otorhinolaryngologic Surgical Procedures ,Otolaryngology ,Nasopharynx ,Humans ,Asymptomatic Infections ,Pandemics ,Personal Protective Equipment ,Physical Examination - Abstract
The WHO announced the coronavirus disease 2019 (COVID-19) outbreak as a pandemic in February 2020 with over 15 million confirmed cases of COVID-19 globally to date. Otolaryngologists are at a high risk of contracting COVID-19 during this pandemic if there is inadequate and improper personal protective equipment provision, as we are dealing with diseases of the upper-aerodigestive tract and routinely engaged in aerosol-generating procedures.This article discusses the background and transmission route for severe acute respiratory syndrome coronavirus 2, its viral load and temporal profile as well as precaution guidelines in outpatient and operative setting in otorhinolaryngology.As it is evident that COVID-19 can be transmitted at presymptomatic or asymptomatic period of infections, it is essential to practice ear, nose, and throat surgery with high vigilance in a safe and up-to-standard protection level during the pandemic. This article provides a summary for guidelines and recommendations in otorhinolaryngology.
- Published
- 2020
122. Repeated CD45RA‐depleted DLI successfully increases donor chimerism in a patient with beta‐thalassemia major after haploidentical stem cell transplant
- Author
-
Daniel K. L. Cheuk, Pamela Pui Wah Lee, Godfrey Chi-Fung Chan, Shau-Yin Ha, Alan K. S. Chiang, Wilson Y K Chan, and Janette Kwok
- Subjects
Transplantation ,Lymphocyte Transfusion ,Myeloid ,Thymoglobulin ,business.industry ,medicine.medical_treatment ,030232 urology & nephrology ,Hematopoietic stem cell transplantation ,030230 surgery ,Treosulfan ,Donor lymphocyte infusion ,Fludarabine ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Pediatrics, Perinatology and Child Health ,Immunology ,Medicine ,Alemtuzumab ,business ,medicine.drug - Abstract
Allogeneic hematopoietic stem cell transplantation is curative for transfusion-dependent thalassemia, but mixed chimerism (MC) may herald graft rejection. We report a child who failed bone marrow transplant (BMT) from matched unrelated donor (MUD) successfully salvaged with haploidentical peripheral blood stem cell transplant (PBSCT), but had MC in T-lymphocyte compartment despite near-complete donor chimerism in myeloid compartment. MC was successfully improved by repeated CD45RA-depleted donor lymphocyte infusion (DLI). A 2-year-old Chinese girl with beta-thalassemia major underwent 12/12-MUD BMT with HU/AZA/Cy/Flu/Bu/TT conditioning resulted in graft rejection. As donor refused second donation, rescue haploidentical PBSCT was performed with alemtuzumab/fludarabine/treosulfan conditioning. Harvest product was CD3/CD45RA depleted with extra products cryopreserved. Split cell chimerism performed 1-month after haplo-transplant showed 97% mother, 3% MUD, and 0% host for granulocytes but 38% mother, 62% MUD, and 0% host for CD3 + T cells. In view of low haploidentical donor chimerism in T-lymphocyte compartment, CD45RA-depleted DLI using cryopreserved product was performed on day + 38, after thymoglobulin 3 mg/kg given as T-cell depletion 3 days beforehand. T-cell chimerism improved to 51% mother and 49% MUD post-DLI. Second cryopreserved CD45RA-depleted DLI was given 17 days after the first DLI (day + 55), and 100% full chimerism of mother's T cells was gradually established without significant graft-versus-host disease (GVHD) or viral reactivation. To conclude, split lineage chimerism determination is beneficial to guide management strategy. For MC in T-cell compartment, CD45RA-depleted DLI is a potential alternative to unselected T cells as it carries lower risk of GVHD and infection.
- Published
- 2020
- Full Text
- View/download PDF
123. Hypersonic shock impingement on a heated flat plate at Mach 7 flight enthalpy
- Author
-
Ananthanarayanan Veeraragavan, Wilson Y. K. Chan, Eric Won Keun Chang, and Timothy J. McIntyre
- Subjects
Overall pressure ratio ,Shock wave ,020301 aerospace & aeronautics ,Hypersonic speed ,Materials science ,Mechanical Engineering ,Hypersonic flight ,02 engineering and technology ,Mechanics ,Condensed Matter Physics ,01 natural sciences ,010305 fluids & plasmas ,Shock (mechanics) ,Flow separation ,symbols.namesake ,0203 mechanical engineering ,Mach number ,Mechanics of Materials ,0103 physical sciences ,symbols ,Supersonic speed - Abstract
Elevated wall temperatures and impinging shock interactions are prevalent features in hypersonic flight. Currently, there is a lack of literature regarding experimental studies examining both features in a flight-representative environment. This work details hot-wall, hypersonic, impinging shock/boundary-layer interaction experiments performed in the T4 Stalker Tube. The model configuration was a two-dimensional heated flat plate and a shock generator. The surface of the graphite flat plate was resistively heated to a mean temperature from and a lower unit Reynolds number. Moreover, the scaled separation of the present data showed a high discrepancy with existing separation correlations developed from a supersonic impinging shock and a hypersonic compression ramp, mainly due to the higher shock strength. Instead, the present data followed a scaling law that includes the pressure ratio across the impinging shock with a slight dependence on the wall temperature ratio.
- Published
- 2020
- Full Text
- View/download PDF
124. Profiling of extracellular vesicles in oral cancer, from transcriptomics to proteomics
- Author
-
Muhammad Kashif Riaz, Katie Meehan, Jason Y. K. Chan, Leanne L. Leung, and Xinyu Qu
- Subjects
0301 basic medicine ,Proteomics ,Cancer Research ,Cell ,Disease ,Transcriptome ,03 medical and health sciences ,Extracellular Vesicles ,0302 clinical medicine ,Biomarkers, Tumor ,Medicine ,Animals ,Humans ,Clinical significance ,Tumor microenvironment ,business.industry ,Gene Expression Profiling ,Cancer ,medicine.disease ,Review article ,030104 developmental biology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Cancer research ,Mouth Neoplasms ,business - Abstract
Oral cancers occurring in different subsites can have distinct etiologies' and are a significant problem worldwide. In general, the incidence of oral cancers has declined over the last decade due to improvements in modifiable risk factors (tobacco and alcohol consumption). However, recent data suggest that the incidence of squamous cell carcinomas in the oral tongue and oropharynx are increasing. Human papilloma virus (HPV) is an important risk factor for oropharyngeal cancer and is associated with better treatment responses when compared with HPV-unrelated oropharyngeal cancer. Regardless of the subsite, there are no clinically available biomarkers for the early detection of these cancers and many are detected at an advanced stage and are associated with poor 5-year survival rates. Tumor tissue and serial needle biopsies are used to diagnose and prognosticate oral cancers but have important limitations. Besides being invasive and physically painful, these types of biopsies offer a limited view of a complex tumor due to inter- and intra-tumoral heterogeneity and a dynamic tumor microenvironment. Liquid biopsies offer a promising and alternative way to measure disease in real-time. Extracellular vesicles (EVs) are small particles that are secreted by all cells types and can be readily isolated from a wide range of biofluids. EVs are structurally stable and can horizontally transfer bioactive molecules to distant sites throughout the body in concentrated forms that exceed what can be delivered in a soluble format. As EVs represent their cell of origin, biofluid derived EVs are heterogeneous and are comprised of a complex repertoire of host- and cancer-derived particles. This review article has focused on studies that have used transcriptomics and proteomics to explore the function and clinical significance of EVs in oral cavity and oropharyngeal cancers.
- Published
- 2020
125. Extracellular Vesicles in Head and Neck Cancer: A Potential New Trend in Diagnosis, Prognosis, and Treatment
- Author
-
Jing-Woei Li, Xinyu Qu, Jason Y. K. Chan, and Katie Meehan
- Subjects
Cell type ,diagnosis ,Disease ,Review ,Bioinformatics ,Medical Oncology ,Extracellular vesicles ,Catalysis ,Unmet needs ,Inorganic Chemistry ,lcsh:Chemistry ,Immune system ,medicine ,Biomarkers, Tumor ,Animals ,Humans ,Physical and Theoretical Chemistry ,Practice Patterns, Physicians' ,Molecular Biology ,lcsh:QH301-705.5 ,Spectroscopy ,therapy ,business.industry ,Organic Chemistry ,Head and neck cancer ,Cancer ,General Medicine ,medicine.disease ,Prognosis ,Computer Science Applications ,Biomarker (cell) ,lcsh:Biology (General) ,lcsh:QD1-999 ,Head and Neck Neoplasms ,head and neck cancer ,business ,extracellular vesicles - Abstract
Head and neck cancer (HNC) is a fatal and debilitating disease that is characterized by steady, poor survival rates despite advances in treatment. There is an urgent and unmet need to improve our understanding of what drives this insidious cancer and causes poor outcomes. Extracellular vesicles (EVs) are small vesicles that originate from tumor cells, immune cells, and other cell types and are secreted into plasma, saliva, and other bio-fluids. EVs represent dynamic, real-time changes of cells and offer an exciting opportunity to improve our understanding of HNC biology that may translate to improved clinical practice. Considering the amplified interest in EVs, we have sought to provide a contemporary review of the most recent and salient literature that is shaping the field. Herein, we discuss the functionality of EVs in HNCs and their clinical potential with regards to biomarker and therapeutic capabilities.
- Published
- 2020
126. Complementary Deep and Shallow Learning with Boosting for Public Transportation Safety
- Author
-
Xingzhao Qiu, Shengda Luo, Jan Y. K. Chan, Alex Po Leung, and Haozhi Huang
- Subjects
Automobile Driving ,Boosting (machine learning) ,Computer science ,Feature extraction ,Big data ,02 engineering and technology ,controller area network ,Machine learning ,computer.software_genre ,lcsh:Chemical technology ,Biochemistry ,Article ,Analytical Chemistry ,Automation ,Artificial Intelligence ,0502 economics and business ,0202 electrical engineering, electronic engineering, information engineering ,lcsh:TP1-1185 ,Electrical and Electronic Engineering ,Instrumentation ,transportation ,050210 logistics & transportation ,business.industry ,Deep learning ,05 social sciences ,deep learning ,Atomic and Molecular Physics, and Optics ,machine learning ,Public transport ,020201 artificial intelligence & image processing ,Artificial intelligence ,business ,computer - Abstract
To monitor road safety, billions of records can be generated by Controller Area Network bus each day on public transportation. Automation to determine whether certain driving behaviour of drivers on public transportation can be considered safe on the road using artificial intelligence or machine learning techniques for big data analytics has become a possibility recently. Due to the high false classification rates of the current methods, our goal is to build a practical and accurate method for road safety predictions that automatically determine if the driving behaviour is safe on public transportation. In this paper, our main contributions include (1) a novel feature extraction method because of the lack of informative features in raw CAN bus data, (2) a novel boosting method for driving behaviour classification (safe or unsafe) to combine advantages of deep learning and shallow learning methods with much improved performance, and (3) an evaluation of our method using a real-world data to provide accurate labels from domain experts in the public transportation industry for the first time. The experiments show that the proposed boosting method with our proposed features outperforms seven other popular methods on the real-world dataset by 5.9% and 5.5%.
- Published
- 2020
127. The role of microRNA in cisplatin resistance or sensitivity
- Author
-
Michael Cf Tong, Jason Y. K. Chan, George G. Chen, Shaoming Zhou, Mo-Xian Chen, Shanshan Wang, Mingyue Li, Shuqi Qiu, Wei Guo, Yi Liu, C. Andrew van Hasselt, Lingbin Xue, Alexander C. Vlantis, Xianhai Zeng, Shucai Yang, and Bao-guang Hu
- Subjects
0301 basic medicine ,Clinical Biochemistry ,Antineoplastic Agents ,Apoptosis ,03 medical and health sciences ,0302 clinical medicine ,Neoplasms ,Drug Discovery ,microRNA ,Medicine ,Animals ,Humans ,Pharmacology ,Cisplatin ,business.industry ,Cisplatin resistance ,Cancer ,medicine.disease ,MicroRNAs ,030104 developmental biology ,Chemotherapy Drugs ,Drug Resistance, Neoplasm ,030220 oncology & carcinogenesis ,Cancer research ,Molecular Medicine ,Neoplasm Recurrence, Local ,business ,medicine.drug - Abstract
Cisplatin is a chemotherapy drug that has been used to treat a number of cancers for decades, and is still one of the most commonly used anti-cancer agents. However, some patients do not respond to cisplatin while other patients who were originally sensitive to cisplatin eventually develop chemoresistance, leading to treatment failure or/and tumor recurrence.Different mechanisms contribute to cisplatin resistance or sensitivity, involving multiple pathways or/and processes such as DNA repair, DNA damage response, drug transport, and apoptosis. Among the various mechanisms, it appears that microRNAs play an important role in determining the resistance or sensitivity. In this article, we analyzed and summarized recent findings in this area, with the aim that these data can aid further research and understanding, leading to the eventual reduction of cisplatin resistance.microRNAs can positively or negatively regulate cisplatin resistance by acting on molecules or/and pathways related to apoptosis, autophagy, hypoxia, cancer stem cells, NF-κB, and Notch1. It appears that the modulation of relevant microRNAs can effectively re-sensitize cancer cells to cisplatin regimen in certain types of cancers including breast, colorectal, gastric, liver, lung, ovarian, prostate, testicular, and thyroid cancers.
- Published
- 2020
128. MAPK pathway mutations in head and neck cancer affect immune microenvironments and ErbB3 signaling
- Author
-
Jessie Sze Wing Tse, Wenying Piao, Sharon Suet Man Chan, Yuchen Liu, Alexandria Lau, Vivian Wai Yan Lui, Hui Li, Chin Wang Lau, Hoi Lam Ngan, Jason Y. K. Chan, Yu-xiong Su, Andrew Yuon Fong, Peony Hiu Yan Poon, Kwok Wai Lo, Jennifer R. Grandis, Chun Kit Yeung, Gordon B. Mills, and Sze Man Chan
- Subjects
0301 basic medicine ,MAPK/ERK pathway ,Male ,Receptor, ErbB-3 ,Health, Toxicology and Mutagenesis ,Plant Science ,Kaplan-Meier Estimate ,Cohort Studies ,0302 clinical medicine ,MAP2K1 ,ErbB-3 ,80 and over ,Tumor Microenvironment ,ERBB3 ,Gene Regulatory Networks ,Research Articles ,Cancer ,Aged, 80 and over ,Tumor ,Ecology ,Middle Aged ,Phenotype ,Head and Neck Neoplasms ,030220 oncology & carcinogenesis ,Female ,Mitogen-Activated Protein Kinases ,Research Article ,Receptor ,Adult ,MAP Kinase Signaling System ,Biochemistry, Genetics and Molecular Biology (miscellaneous) ,Cell Line ,03 medical and health sciences ,Young Adult ,Rare Diseases ,Cell Line, Tumor ,medicine ,Biomarkers, Tumor ,Genetics ,Humans ,HRAS ,Dental/Oral and Craniofacial Disease ,Aged ,Tumor microenvironment ,business.industry ,Squamous Cell Carcinoma of Head and Neck ,medicine.disease ,Head and neck squamous-cell carcinoma ,stomatognathic diseases ,030104 developmental biology ,Good Health and Well Being ,Mutation ,Cancer research ,business ,Transcriptome ,CD8 ,Biomarkers - Abstract
MAPK mutations favor HNSCC survival, revealing the broad clinical utility of MAPK pathway mutations in prognosis and potentially in precision immunotherapy., MAPK pathway mutations affect one-fifth of head and neck squamous cell carcinoma (HNSCC). Unexpectedly, MAPK pathway aberrations are associated with remarkably long patient survival, even among patients with TP53 mutations (median ∼14 yr). We explored underlying outcome-favoring mechanisms with omics followed by preclinical models. Strikingly, multiple hotspot and non-hotspot MAPK mutations (A/BRAF, HRAS, MAPK1, and MAP2K1/2) all abrogated ErbB3 activation, a well-established HNSCC progression signal. Inhibitor studies functionally defined ERK activity negatively regulating phospho-ErbB3 in MAPK-mutants. Furthermore, pan-pathway immunoprofiling investigations identified MAPK-mutant tumors as the only “CD8+ T-cell–inflamed” tumors inherently bearing high-immunoreactive, constitutive cytolytic tumor microenvironments. Immunocompetent MAPK-mutant HNSCC models displayed active cell death and massive CD8+ T-cell recruitment in situ. Consistent with CD8+ T-inflamed phenotypes, MAPK-mutant HNSCC patients, independent of tumor-mutational burden, survived 3.3–4 times longer than WT patients with anti-PD1/PD-L1 immunotherapies. Similar prognosticity was noted in pan-cancers. We uncovered clinical, signaling, and immunological uniqueness of MAPK-mutant HNSCC with potential biomarker utilities predicting favorable patient survival.
- Published
- 2020
129. Procedural precautions and personal protective equipment during head and neck instrumentation in the COVID ‐19 era
- Author
-
Joseph A. Califano, Jason Y. K. Chan, Bharat A. Panuganti, and John Pang
- Subjects
high-risk procedures ,Infectious Disease Transmission ,high‐risk procedures ,Patient-to-Professional ,0302 clinical medicine ,COVID-19 Testing ,Extant taxon ,Health care ,030212 general & internal medicine ,Viral ,030223 otorhinolaryngology ,Head and neck ,Head neck surgery ,Air Pollutants ,Special Issue ,perioperative protocols ,Occupational ,personal protective equipment ,Medical emergency ,Coronavirus Infections ,medicine.medical_specialty ,Infectious Disease Transmission, Patient-to-Professional ,Coronavirus disease 2019 (COVID-19) ,Pneumonia, Viral ,Clinical Sciences ,Air Pollutants, Occupational ,03 medical and health sciences ,Betacoronavirus ,Rare Diseases ,COVID‐19 ,Occupational Exposure ,medicine ,Humans ,Instrumentation (computer programming) ,Dental/Oral and Craniofacial Disease ,Personal protective equipment ,Pandemics ,Personal Protective Equipment ,Infection Control ,business.industry ,Clinical Laboratory Techniques ,SARS-CoV-2 ,Prevention ,COVID-19 ,Pneumonia ,medicine.disease ,Otorhinolaryngologic Surgical Procedures ,Good Health and Well Being ,Otorhinolaryngology ,Dentistry ,business - Abstract
Background Otolaryngologists represent a subset of health care workers uniquely vulnerable to COVID‐19 transmission. Given the segmentation of extant guidelines concerning precautions and protective equipment for SARS‐CoV2, we aimed to provide consolidated recommendations regarding appropriate personal protective equipment (PPE) in head neck surgery during the COVID‐19 era. Methods Guidelines published by international and US governing bodies were reviewed in conjunction with published literature concerning COVID‐19 transmission risk, testing, and PPE, to compile situation‐specific recommendations for head and neck providers managing COVID‐19 patients. Results High‐quality data regarding the aerosolization potential of head and neck instrumentation and appropriate PPE during head and neck surgeries are lacking. However, extrapolation of recommendations by governing bodies suggests strongly that head and neck mucosal instrumentation warrants strict adherence to airborne‐level precautions. Conclusion We present a series of situation‐specific recommendations for PPE use and other procedural precautions for otolaryngology providers to consider in the COVID‐19 era.
- Published
- 2020
- Full Text
- View/download PDF
130. Status and strategies for the management of head and neck cancer during COVID‐19 pandemic: Indian scenario
- Author
-
Jason Y. K. Chan, Nishant Agrawal, Vipin Arora, Anand Gupta, Yu-xiong Su, Deepa Nair, and F. Christopher Holsinger
- Subjects
Adult ,Male ,Coping (psychology) ,medicine.medical_specialty ,Safety Management ,Coronavirus disease 2019 (COVID-19) ,strategies for management ,Pneumonia, Viral ,India ,Cancer Care Facilities ,Tertiary Care Centers ,03 medical and health sciences ,0302 clinical medicine ,Indian scenario ,COVID‐19 ,Surveys and Questionnaires ,Pandemic ,Medicine ,Humans ,Disease management (health) ,Intensive care medicine ,Pandemics ,Academic Medical Centers ,business.industry ,Special Issue ,pandemic ,Patient Selection ,Head and neck cancer ,Cancer ,COVID-19 ,Disease Management ,Middle Aged ,medicine.disease ,Surgical Oncology ,Otorhinolaryngology ,Smokeless tobacco ,Elective Surgical Procedures ,Head and Neck Neoplasms ,030220 oncology & carcinogenesis ,030221 ophthalmology & optometry ,head and neck cancer ,Female ,business ,Coronavirus Infections - Abstract
In India, oral cancer is the most common head and neck cancer (HNC) in men, mainly caused by the consumption of smoked and smokeless tobacco. During the current pandemic, delaying surgery for even 1 or 2 months may lead to more extensive surgery or inoperability, where only supportive care can be provided. Being semi‐emergent in nature, treatment for these patients is currently on hold or delayed in most centers across the country. This study was conducted to assess the impact of COVID‐19 pandemic and inability of the health system to treat HNC in a timely fashion and how surgeons are coping to this emergent situation. This article highlights the situation in India, a country burdened with one of the highest incidence rates of HNC.
- Published
- 2020
131. Why and when do consumers perform green behaviors? An examination of regulatory focus and ethical ideology
- Author
-
Lili Wenli Zou and Ricky Y. K. Chan
- Subjects
Marketing ,Social comparison theory ,media_common.quotation_subject ,05 social sciences ,Regulatory focus theory ,Affect (psychology) ,Promotion (rank) ,Idealism ,0502 economics and business ,Survey data collection ,050211 marketing ,Ideology ,Psychology ,Social psychology ,050203 business & management ,Relativism ,media_common - Abstract
This research builds upon Hunt and Vitell's ethical decision-making model to examine consumers' engagement in green behaviors. Using survey data collected from Hong Kong and the United States and with structural equation modelling and bootstrap analyses, it shows that consumers' prevention focus and promotion focus positively affect their ethical idealism (βHK,US = 0.29, 0.19) and relativism (βHK,US = 0.15, 0.21), respectively. Furthermore, idealism positively influences consumers' corresponding ethical judgments (βHK,US = 0.18, 0.31) and decisions, and this influence is higher when the focal green behavior is high in moral intensity (βHK,US = 0.13, 0.12). Contrarily, ethical relativism has a negative impact on the same judgments (βHK,US = −0.11, −0.10) and decisions, and this impact is stronger when consumers' attention to social comparison information is low (βHK,US = 0.10, 0.11). This research contributes to the literature on green behaviors, regulatory focus and consumer ethics, and offers practical insights into promoting green behaviors among consumers.
- Published
- 2019
- Full Text
- View/download PDF
132. Managing head and neck cancer patients with tracheostomy or laryngectomy during the COVID ‐19 pandemic
- Author
-
Heather M. Starmer, Ann Kearney, Maxwell P. Kligerman, Edward J. Damrose, John B. Sunwoo, Neelaysh Vukkadala, F. Christopher Holsinger, Raymond K. Y. Tsang, and Jason Y. K. Chan
- Subjects
Male ,medicine.medical_specialty ,medicine.medical_treatment ,Pneumonia, Viral ,Laryngectomy ,Context (language use) ,Risk Assessment ,SARS‐CoV‐2 ,Occupational safety and health ,03 medical and health sciences ,Patient safety ,Tracheostomy ,0302 clinical medicine ,COVID‐19 ,Pandemic ,Disease Transmission, Infectious ,medicine ,Humans ,030223 otorhinolaryngology ,Intensive care medicine ,Pandemics ,Personal Protective Equipment ,Personal protective equipment ,Occupational Health ,Evidence-Based Medicine ,Special Issue ,business.industry ,Head and neck cancer ,COVID-19 ,Evidence-based medicine ,medicine.disease ,Head and Neck Cancer ,United States ,Surgical Oncology ,Aerosolization ,Otorhinolaryngology ,Head and Neck Neoplasms ,030220 oncology & carcinogenesis ,Communicable Disease Control ,Practice Guidelines as Topic ,Female ,Patient Safety ,Coronavirus Infections ,business - Abstract
Head and neck cancer patients with tracheostomies and laryngectomies, as well as their healthcare providers, face unique challenges in the context of the current COVID‐19 pandemic. This document consolidates best available evidence to date and presents recommendations to minimize the risks of aerosolization and SARS‐CoV‐2 exposures in both the inpatient and outpatient settings. The cornerstones of these recommendations include the use of closed‐circuit ventilation whenever possible, cuffed tracheostomy tubes, judicious use of heat moisture exchange units, appropriate personal protective equipment for providers and patients, meticulous hand hygiene, and minimal manipulation of tracheostomy tubes.
- Published
- 2020
- Full Text
- View/download PDF
133. Practical Aspects of Otolaryngologic Clinical Services During the 2019 Novel Coronavirus Epidemic: An Experience in Hong Kong
- Author
-
Jason Y. K. Chan, Wayne Lam, and Eddy W.Y. Wong
- Subjects
Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Pneumonia, Viral ,Comorbidity ,Betacoronavirus ,Otolaryngology ,Pandemic ,Disease Transmission, Infectious ,Medicine ,Humans ,Pandemics ,biology ,Viral Epidemiology ,business.industry ,SARS-CoV-2 ,COVID-19 ,medicine.disease ,biology.organism_classification ,Virology ,Pneumonia ,Otorhinolaryngologic Diseases ,Otorhinolaryngology ,Hong Kong ,Surgery ,business ,Coronavirus Infections ,Disease transmission ,Delivery of Health Care - Published
- 2020
134. Clinical Toxicology Expert Reviewers 2019
- Author
-
Ronald I. Kirschner, Nicholas A. Buckley, Simon H. L. Thomas, Jennifer A. Oakes, Betty S. Chan, Donna Seger, Michael E. Mullins, Thomas Y. K. Chan, Martin F. Wilks, Bruno Mégarbane, J Allister Vale, and Steven A. Seifert
- Subjects
medicine.medical_specialty ,business.industry ,MEDLINE ,Medicine ,Medical physics ,General Medicine ,Clinical toxicology ,Toxicology ,business - Published
- 2020
- Full Text
- View/download PDF
135. Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer.
- Author
-
Jirong Long, Qiuyin Cai, Hyuna Sung, Jiajun Shi, Ben Zhang, Ji-Yeob Choi, Wanqing Wen, Ryan J Delahanty, Wei Lu, Yu-Tang Gao, Hongbing Shen, Sue K Park, Kexin Chen, Chen-Yang Shen, Zefang Ren, Christopher A Haiman, Keitaro Matsuo, Mi Kyung Kim, Ui Soon Khoo, Motoki Iwasaki, Ying Zheng, Yong-Bing Xiang, Kai Gu, Nathaniel Rothman, Wenjing Wang, Zhibin Hu, Yao Liu, Keun-Young Yoo, Dong-Young Noh, Bok-Ghee Han, Min Hyuk Lee, Hong Zheng, Lina Zhang, Pei-Ei Wu, Ya-Lan Shieh, Sum Yin Chan, Shenming Wang, Xiaoming Xie, Sung-Won Kim, Brian E Henderson, Loic Le Marchand, Hidemi Ito, Yoshio Kasuga, Sei-Hyun Ahn, Han Sung Kang, Kelvin Y K Chan, Hiroji Iwata, Shoichiro Tsugane, Chun Li, Xiao-Ou Shu, Dae-Hee Kang, and Wei Zheng
- Subjects
Genetics ,QH426-470 - Abstract
Genetic factors play an important role in the etiology of both sporadic and familial breast cancer. We aimed to discover novel genetic susceptibility loci for breast cancer. We conducted a four-stage genome-wide association study (GWAS) in 19,091 cases and 20,606 controls of East-Asian descent including Chinese, Korean, and Japanese women. After analyzing 690,947 SNPs in 2,918 cases and 2,324 controls, we evaluated 5,365 SNPs for replication in 3,972 cases and 3,852 controls. Ninety-four SNPs were further evaluated in 5,203 cases and 5,138 controls, and finally the top 22 SNPs were investigated in up to 17,423 additional subjects (7,489 cases and 9,934 controls). SNP rs9485372, near the TGF-β activated kinase (TAB2) gene in chromosome 6q25.1, showed a consistent association with breast cancer risk across all four stages, with a P-value of 3.8×10(-12) in the combined analysis of all samples. Adjusted odds ratios (95% confidence intervals) were 0.89 (0.85-0.94) and 0.80 (0.75-0.86) for the A/G and A/A genotypes, respectively, compared with the genotype G/G. SNP rs9383951 (P = 1.9×10(-6) from the combined analysis of all samples), located in intron 5 of the ESR1 gene, and SNP rs7107217 (P = 4.6×10(-7)), located at 11q24.3, also showed a consistent association in each of the four stages. This study provides strong evidence for a novel breast cancer susceptibility locus represented by rs9485372, near the TAB2 gene (6q25.1), and identifies two possible susceptibility loci located in the ESR1 gene and 11q24.3, respectively.
- Published
- 2012
- Full Text
- View/download PDF
136. Effects of Salivary Mg on Head and Neck Carcinoma via TRPM7
- Author
-
Vivian Wai Yan Lui, Jukka Pekka Matinlinna, Jason Y. K. Chan, Wei Qiao, Xinmiao Lan, James K.H. Tsoi, Z. Hu, H.X. Ma, Yu-xiong Su, K.W.K. Yeung, and D.L.W. Kwong
- Subjects
0301 basic medicine ,Saliva ,Mice, Nude ,TRPM Cation Channels ,mTORC1 ,Protein Serine-Threonine Kinases ,medicine.disease_cause ,Proto-Oncogene Mas ,Mice ,03 medical and health sciences ,0302 clinical medicine ,TRPM7 ,Extracellular ,medicine ,Animals ,Humans ,Magnesium ,General Dentistry ,Protein kinase B ,PI3K/AKT/mTOR pathway ,Cell Proliferation ,business.industry ,Carcinoma ,030206 dentistry ,030104 developmental biology ,Head and Neck Neoplasms ,Cell culture ,Cancer research ,Carcinogenesis ,business ,Signal Transduction - Abstract
Magnesium (Mg) has been known to play vital roles in regulating growth and various metabolic processes. In recent years, the association between Mg and tumorigenesis has raised more and more attention. However, the effects of Mg on the progression of head and neck carcinoma (HNC), as well as the mechanism behind it, remain undefined. In this study, the roles of Mg in tumorigenic activities were tested in CAL27 and FaDu cells as well as in a xenograft tumor model in nude mice. We demonstrated that a moderate increase in extracellular Mg contributed to the proliferation, migration, and invasion of 2 HNC cell lines, while the addition of Mg in drinking water promoted the growth of xenograft tumors in mice without altering their serum Mg levels. Moreover, TRPM7, a major Mg transporter, was shown to be essential for the tumorigenic activities of HNC and the Mg-induced promotive effects on HNC cells and was further shown to be associated with the activation of AKT/mTOR (mammalian target of rapamycin) signaling. In a preliminary clinical study, we determined the Mg ion concentrations in the stimulated saliva from 72 patients with nasopharynx carcinoma and 12 healthy individuals. Our data revealed that the salivary Mg levels of subjects with nasopharynx carcinoma were significantly higher than those of the healthy controls. This is correlated with our finding showing TRPM7 to be overexpressed in tumor tissues harvested from 9 patients with HNC. Therefore, we can conclude that salivary Mg level, within a certain range, could act as a risk factor for the progression of HNC, which involves the activation of AKT/mTOR signaling pathways through the TRPM7 channel. The control of salivary Mg level and the intervention of TRPM7 should not be ignored during the study of HNC.
- Published
- 2018
- Full Text
- View/download PDF
137. Freejet Testing of the HIFiRE 7 Scramjet Flowpath at Mach 7.5
- Author
-
Wilson Y. K. Chan, Milinda V. Suraweera, Sarah A. Razzaqi, Michael K. Smart, and James C. Turner
- Subjects
020301 aerospace & aeronautics ,Materials science ,business.industry ,Mechanical Engineering ,Aerospace Engineering ,02 engineering and technology ,Static pressure ,Heat transfer coefficient ,01 natural sciences ,010305 fluids & plasmas ,symbols.namesake ,Fuel Technology ,0203 mechanical engineering ,Mach number ,Space and Planetary Science ,0103 physical sciences ,symbols ,Scramjet ,Aerospace engineering ,business ,Clean configuration - Abstract
Results are presented on the freejet testing of a 75%-scale replica of the HIFiRE 7 scramjet. The HIFiRE 7 scramjet flowpath includes a two-dimensional forebody, a rectangular-to-elliptical shape t...
- Published
- 2018
- Full Text
- View/download PDF
138. Impact of perk expenditures and marketing expenditures on corporate performance in China: The moderating role of political connections
- Author
-
Tak Yan Leung, Louis T. W. Cheng, and Ricky Y. K. Chan
- Subjects
Marketing ,Politics ,050208 finance ,0502 economics and business ,05 social sciences ,Business ,Market share ,China ,Emerging markets ,050203 business & management - Abstract
This study examines the performance implications of guanxi-related perk expenditures among listed Chinese firms. Specifically, it investigates how these expenditures influence long-term market-based corporate performance (Tobin's Q and market share) as compared with marketing expenditures. It also examines if political connections moderate this influence. Overall, the findings suggest that guanxi-related perks play an essential marketing role in enhancing long-term corporate success. Furthermore, although marketing expenditures exert much stronger influence on Tobin's Q than guanxi-related perks do, they exert no significant influence on market share. In summary, despite firms' much heavier investments in traditional marketing activities than guanxi-related perk activities, the findings highlight the significant performance contribution that guanxi-related perks can still make to a firm. Moreover, this study reveals that political connections weaken the positive impact of guanxi-related perks on both performance measures, thus reminding executives of the dampening effect of these connections on the effective use of perk spending.
- Published
- 2018
- Full Text
- View/download PDF
139. Spatial domain entertainment audio decompression/compression.
- Author
-
Y. K. Chan and Ka Him Kevin Tam
- Published
- 2014
- Full Text
- View/download PDF
140. Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer.
- Author
-
Jie Chen, Ana R Gomes, Lara J Monteiro, San Yu Wong, Lai Han Wu, Ting-Ting Ng, Christina T Karadedou, Julie Millour, Ying-Chi Ip, Yuen Nei Cheung, Andrew Sunters, Kelvin Y K Chan, Eric W-F Lam, and Ui-Soon Khoo
- Subjects
Medicine ,Science - Abstract
BackgroundThe PI3K-Akt signal pathway plays a key role in tumorigenesis and the development of drug-resistance. Cytotoxic chemotherapy resistance is linked to limited therapeutic options and poor prognosis.Methodology/principal findingsExamination of FOXO3a and phosphorylated-Akt (P-Akt) expression in breast cancer tissue microarrays showed nuclear FOXO3a was associated with lymph node positivity (p = 0.052), poor prognosis (p = 0.014), and P-Akt expression in invasive ductal carcinoma. Using tamoxifen and doxorubicin-sensitive and -resistant breast cancer cell lines as models, we found that doxorubicin- but not tamoxifen-resistance is associated with nuclear accumulation of FOXO3a, consistent with the finding that sustained nuclear FOXO3a is associated with poor prognosis. We also established that doxorubicin treatment induces proliferation arrest and FOXO3a nuclear relocation in sensitive breast cancer cells. Induction of FOXO3a activity in doxorubicin-sensitive MCF-7 cells was sufficient to promote Akt phosphorylation and arrest cell proliferation. Conversely, knockdown of endogenous FOXO3a expression reduced PI3K/Akt activity. Using MDA-MB-231 cells, in which FOXO3a activity can be induced by 4-hydroxytamoxifen, we showed that FOXO3a induction up-regulates PI3K-Akt activity and enhanced doxorubicin resistance. However FOXO3a induction has little effect on cell proliferation, indicating that FOXO3a or its downstream activity is deregulated in the cytotoxic drug resistant breast cancer cells. Thus, our results suggest that sustained FOXO3a activation can enhance hyperactivation of the PI3K/Akt pathway.Conclusions/significanceTogether these data suggest that lymph node metastasis and poor survival in invasive ductal breast carcinoma are linked to an uncoupling of the Akt-FOXO3a signaling axis. In these breast cancers activated Akt fails to inactivate and re-localize FOXO3a to the cytoplasm, and nuclear-targeted FOXO3a does not induce cell death or cell cycle arrest. As such, sustained nuclear FOXO3a expression in breast cancer may culminate in cancer progression and the development of an aggressive phenotype similar to that observed in cytotoxic chemotherapy resistant breast cancer cell models.
- Published
- 2010
- Full Text
- View/download PDF
141. Nasopharyngeal Brush Epstein Barr Viral DNA in the Detection of Locally Recurrent Nasopharyngeal Carcinoma
- Author
-
Jason Y. K. Chan, Ronald Lai, Zenon W C Yeung, Allen Chan, and Jacky W K Lam
- Subjects
Cancer Research ,Oncology ,Epstein barr ,business.industry ,law ,Medicine ,Brush ,Recurrent Nasopharyngeal Carcinoma ,Oral Surgery ,Dna viral ,business ,Virology ,law.invention - Published
- 2021
- Full Text
- View/download PDF
142. Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium.
- Author
-
Jirong Long, Qiuyin Cai, Xiao-Ou Shu, Shimian Qu, Chun Li, Ying Zheng, Kai Gu, Wenjing Wang, Yong-Bing Xiang, Jiarong Cheng, Kexin Chen, Lina Zhang, Hong Zheng, Chen-Yang Shen, Chiun-Sheng Huang, Ming-Feng Hou, Hongbing Shen, Zhibin Hu, Furu Wang, Sandra L Deming, Mark C Kelley, Martha J Shrubsole, Ui Soon Khoo, Kelvin Y K Chan, Sum Yin Chan, Christopher A Haiman, Brian E Henderson, Loic Le Marchand, Motoki Iwasaki, Yoshio Kasuga, Shoichiro Tsugane, Keitaro Matsuo, Kazuo Tajima, Hiroji Iwata, Bo Huang, Jiajun Shi, Guoliang Li, Wanqing Wen, Yu-Tang Gao, Wei Lu, and Wei Zheng
- Subjects
Genetics ,QH426-470 - Abstract
Genetic factors play an important role in the etiology of breast cancer. We carried out a multi-stage genome-wide association (GWA) study in over 28,000 cases and controls recruited from 12 studies conducted in Asian and European American women to identify genetic susceptibility loci for breast cancer. After analyzing 684,457 SNPs in 2,073 cases and 2,084 controls in Chinese women, we evaluated 53 SNPs for fast-track replication in an independent set of 4,425 cases and 1,915 controls of Chinese origin. Four replicated SNPs were further investigated in an independent set of 6,173 cases and 6,340 controls from seven other studies conducted in Asian women. SNP rs4784227 was consistently associated with breast cancer risk across all studies with adjusted odds ratios (95% confidence intervals) of 1.25 (1.20-1.31) per allele (P = 3.2 x 10(-25)) in the pooled analysis of samples from all Asian samples. This SNP was also associated with breast cancer risk among European Americans (per allele OR = 1.19, 95% CI = 1.09-1.31, P = 1.3 x 10(-4), 2,797 cases and 2,662 controls). SNP rs4784227 is located at 16q12.1, a region identified previously for breast cancer risk among Europeans. The association of this SNP with breast cancer risk remained highly statistically significant in Asians after adjusting for previously-reported SNPs in this region. In vitro experiments using both luciferase reporter and electrophoretic mobility shift assays demonstrated functional significance of this SNP. These results provide strong evidence implicating rs4784227 as a functional causal variant for breast cancer in the locus 16q12.1 and demonstrate the utility of conducting genetic association studies in populations with different genetic architectures.
- Published
- 2010
- Full Text
- View/download PDF
143. Protein Concentration Determination in Latex Glove Using Biocompatibility Morphological Mean Test
- Author
-
C. K., Toa, primary, K. S., Sim, additional, and Y. K., Chan, additional
- Published
- 2020
- Full Text
- View/download PDF
144. Reduced lysosomal clearance of autophagosomes promotes survival and colonization ofHelicobacter pylori
- Author
-
Sidney Yu, Tony Gin, Sunny H. Wong, Siew C. Ng, Thomas K. W. Ling, William K.K. Wu, Jason Y. K. Chan, Zhan G. Xiao, Cynthia K. Cheung, Ming X. Li, Wei Hu, Long F Li, Gary Tse, Maggie Ht Wang, J. Ross Fitzgerald, Ho Ko, Chi H. Cho, Justin C.Y. Wu, Matthew T. V. Chan, Jing Shen, Hassan Ashktorab, Duane T. Smoot, Francis K.L. Chan, Jun Yu, and Lin Zhang
- Subjects
0301 basic medicine ,biology ,ATG5 ,Autophagy ,BECN1 ,Helicobacter pylori ,biology.organism_classification ,Pathology and Forensic Medicine ,Cell biology ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Lysosome ,medicine ,Xenophagy ,Helicobacter ,Intracellular - Abstract
Evasion of autophagy is key for intracellular survival of bacteria in host cells, but its involvement in persistent infection by Helicobacter pylori, a bacterium identified to invade gastric epithelial cells, remains obscure. The aim of this study was to functionally characterize the role of autophagy in H. pylori infection. Autophagy was assayed in H. pylori-infected human gastric epithelium and the functional role of autophagy was determined via genetic or pharmacological ablation of autophagy in mouse and cell line models of H. pylori infection. Here, we showed that H. pylori inhibited lysosomal function and thereby promoted the accumulation of autophagosomes in gastric epithelial cells. Importantly, inhibiting autophagosome formation by pharmacological inhibitors or genetic ablation of BECN1 or ATG5 reduced H. pylori intracellular survival, whereas inhibition of lysosomal functions exerted an opposite effect. Further experiments demonstrated that H. pylori inhibited lysosomal acidification and the retrograde trafficking of mannose-6-phosphate receptors, both of which are known to positively regulate lysosomal function. We conclude that H. pylori subverts autophagy into a pro-survival mechanism through inhibition of lysosomal clearance of autophagosomes. Disruption of autophagosome formation offers a novel strategy to reduce H. pylori colonization in human stomachs. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
- Published
- 2018
- Full Text
- View/download PDF
145. Surgical salvage of recurrent nasopharyngeal cancer- a multi-institutional review
- Author
-
Jason Y. K. Chan, Kai-Ping Chang, Raymond K. Y. Tsang, Kimberley Liqin Kiong, Constance Teo, Chih-Yen Chien, Jimmy Yu Wai Chan, Sheng-Po Hao, Clarisse Chu, Eddy W.Y. Wong, Chwee Ming Lim, Mingyuan Chen, Anna See, and Hiang Khoon Tan
- Subjects
Salvage Therapy ,Cancer Research ,medicine.medical_specialty ,Recurrent nasopharyngeal cancer ,business.industry ,medicine.medical_treatment ,Nasopharyngeal Neoplasms ,Neck dissection ,medicine.disease ,Oncology ,Nasopharyngeal carcinoma ,medicine ,Humans ,Multicenter Studies as Topic ,Radiology ,Neoplasm Recurrence, Local ,Oral Surgery ,business ,Retrospective Studies - Published
- 2021
- Full Text
- View/download PDF
146. Allergic contact dermatitis by ophthalmological medications in Brazil: experience of a dermatology department
- Author
-
E S Novalo Goto, R Fachini Jardim Criado, Paulo Ricardo Criado, and Y K Chan
- Subjects
Periorbital region ,medicine.medical_specialty ,business.industry ,medicine.drug_class ,Antibiotics ,Dermatology department ,Patch test ,Ophthalmic medications ,medicine.disease ,Dermatology ,Cutaneous patch ,Immunology and Allergy ,Medicine ,business ,Allergic contact dermatitis - Abstract
Summary Topical treatments in ophthalmologic therapy are significant for the development of allergic contact dermatitis (ACD) in the periorbital region. Preservatives, antibiotics, glucocorticoids, and beta-blocker eye drops are defined as drugs with the highest sensitizing potential. The unavailability of patch test batteries containing substances of ophthalmological use makes it difficult for this diagnosis. In the present report, we describe six patients who developed ACD induced by different agents presenting in eye drops, confirmed with the cutaneous patch tests. The ACD diagnosis due to ophthalmic medications can be challenging, since many different agents can cause it, and the sensitivity of these cutaneous tests is low. Thus, early diagnosis is essential to avoid the complications of ACD on the skin and ocular disorders related to chronic periorbital eczema.
- Published
- 2021
- Full Text
- View/download PDF
147. Scramjet test flow reconstruction for a large-scale expansion tube, Part 1: quasi-one-dimensional modelling
- Author
-
Rowan J. Gollan, Peter A. Jacobs, Wilson Y. K. Chan, David Gildfind, and Richard G. Morgan
- Subjects
020301 aerospace & aeronautics ,Scale (ratio) ,business.industry ,Computer science ,Mechanical Engineering ,Nozzle ,Rotational symmetry ,General Physics and Astronomy ,02 engineering and technology ,Inflow ,Computational fluid dynamics ,01 natural sciences ,010305 fluids & plasmas ,symbols.namesake ,0203 mechanical engineering ,Mach number ,0103 physical sciences ,symbols ,Scramjet ,Aerospace engineering ,business ,Shock tube - Abstract
Large-scale free-piston driven expansion tubes have uniquely high total pressure capabilities which make them an important resource for development of access-to-space scramjet engine technology. However, many aspects of their operation are complex, and their test flows are fundamentally unsteady and difficult to measure. While computational fluid dynamics methods provide an important tool for quantifying these flows, these calculations become very expensive with increasing facility size and therefore have to be carefully constructed to ensure sufficient accuracy is achieved within feasible computational times. This study examines modelling strategies for a Mach 10 scramjet test condition developed for The University of Queensland’s X3 facility. The present paper outlines the challenges associated with test flow reconstruction, describes the experimental set-up for the X3 experiments, and then details the development of an experimentally tuned quasi-one-dimensional CFD model of the full facility. The 1-D model, which accurately captures longitudinal wave processes, is used to calculate the transient flow history in the shock tube. This becomes the inflow to a higher-fidelity 2-D axisymmetric simulation of the downstream facility, detailed in the Part 2 companion paper, leading to a validated, fully defined nozzle exit test flow.
- Published
- 2017
- Full Text
- View/download PDF
148. Scramjet test flow reconstruction for a large-scale expansion tube, Part 2: axisymmetric CFD analysis
- Author
-
Rowan J. Gollan, Richard G. Morgan, Peter A. Jacobs, Wilson Y. K. Chan, and David Gildfind
- Subjects
020301 aerospace & aeronautics ,Shock (fluid dynamics) ,Mechanical Engineering ,Nozzle ,General Physics and Astronomy ,Pitot tube ,02 engineering and technology ,Inflow ,Mechanics ,Static pressure ,01 natural sciences ,010305 fluids & plasmas ,law.invention ,Physics::Fluid Dynamics ,symbols.namesake ,0203 mechanical engineering ,Mach number ,law ,0103 physical sciences ,symbols ,Scramjet ,Shock tube ,Geology - Abstract
This paper presents the second part of a study aiming to accurately characterise a Mach 10 scramjet test flow generated using a large free-piston-driven expansion tube. Part 1 described the experimental set-up, the quasi-one-dimensional simulation of the full facility, and the hybrid analysis technique used to compute the nozzle exit test flow properties. The second stage of the hybrid analysis applies the computed 1-D shock tube flow history as an inflow to a high-fidelity two-dimensional-axisymmetric analysis of the acceleration tube. The acceleration tube exit flow history is then applied as an inflow to a further refined axisymmetric nozzle model, providing the final nozzle exit test flow properties and thereby completing the analysis. This paper presents the results of the axisymmetric analyses. These simulations are shown to closely reproduce experimentally measured shock speeds and acceleration tube static pressure histories, as well as nozzle centreline static and impact pressure histories. The hybrid scheme less successfully predicts the diameter of the core test flow; however, this property is readily measured through experimental pitot surveys. In combination, the full test flow history can be accurately determined.
- Published
- 2017
- Full Text
- View/download PDF
149. Vastus Lateralis Muscle Free Flap for Skull Base Osteoradionecrosis in Nasopharyngeal Carcinoma
- Author
-
Jason Y. K. Chan, Tor Chiu, Alexander C. Vlantis, and Eddy W.Y. Wong
- Subjects
medicine.medical_specialty ,business.industry ,Osteoradionecrosis ,Granulation tissue ,Soft tissue ,Free flap ,Choanal stenosis ,medicine.disease ,Surgery ,03 medical and health sciences ,Skull ,0302 clinical medicine ,medicine.anatomical_structure ,Nasopharyngeal carcinoma ,030220 oncology & carcinogenesis ,medicine.artery ,otorhinolaryngologic diseases ,medicine ,Neurology (clinical) ,Internal carotid artery ,030223 otorhinolaryngology ,business - Abstract
Objectives To describe the first experience with a free vastus lateralis muscle-only flap to be used to cover and protect the exposed skull base and carotid artery from radiotherapy-induced skull base osteoradionecrosis (ORN). Design Retrospective review of a case series. Setting Tertiary academic medical center. Participants Post treatment nasopharyngeal carcinoma patients with skull base ORN. Main Outcome Measures Coverage of the internal carotid artery (ICA). Results Four patients underwent the procedure. Following the procedure, all patients were documented to have adequate viable soft tissue covering their ICA. Topical nasal steroids were prescribed to all patients as florid granulation tissue was noted to occur overlying the muscle flap in the early postoperative period. There were no flap failures. All patients noted an improvement in speech, cacosmia, and nasal crusting. No significant epistaxis occurred following surgery. Choanal stenosis was noted in three patients. Conclusion For skull base ORN resulting from the treatment of nasopharyngeal carcinoma (NPC) with radiotherapy that fails conservative management, an open approach to the nasopharynx, that allows debridement then placement of a vastus lateralis muscle-only free flap for coverage, offers a unique and viable approach to the management of this challenging condition.
- Published
- 2017
- Full Text
- View/download PDF
150. The Association Between Diabetes and Olfactory Function in Adults
- Author
-
Michael C. F. Tong, Sandra Y. Lin, Esther García-Esquinas, Owen H Ko, and Jason Y. K. Chan
- Subjects
Adult ,Blood Glucose ,Male ,Olfactory system ,medicine.medical_specialty ,National Health and Nutrition Examination Survey ,Physiology ,medicine.medical_treatment ,Anosmia ,030209 endocrinology & metabolism ,Comorbidity ,Olfaction Disorders ,03 medical and health sciences ,Behavioral Neuroscience ,0302 clinical medicine ,Hyposmia ,Physiology (medical) ,Internal medicine ,Diabetes mellitus ,Diabetes Mellitus ,Prevalence ,medicine ,Humans ,Hypoglycemic Agents ,Insulin ,Association (psychology) ,Glycated Hemoglobin ,business.industry ,Confounding ,Nutrition Surveys ,medicine.disease ,United States ,Sensory Systems ,Smell ,Cross-Sectional Studies ,Female ,medicine.symptom ,business ,030217 neurology & neurosurgery - Abstract
Diabetes is a significant chronic disease that in limited studies has been linked with olfactory dysfunction. We investigated the cross-sectional association between diabetes and olfactory dysfunction in 3151 adults aged ≥40 years who participated in US National Health and Nutrition Examination Survey 2013-2014 with information on olfactory dysfunction and diabetes. Diabetes was defined from fasting serum glucose ≥126 mg/dL, oral glucose tolerance test ≥200 mg/dL, HbA1c levels ≥6.5%, physician-diagnosed diabetes, or current use of oral hypoglycemic agents and/or insulin. Self-reported olfactory dysfunction was defined as a positive answer to any of the following questions: 1) "Have you had problem with smell in the past 12 months?"; 2) "Have you had a change in the ability to smell since age 25?", or 3) "Do you have phantom smells?". Participants were considered to have severe hyposmia or anosmia if they had
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.